Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
167000,,5217680,CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.015
167001,,5217688,CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.06
167002,,5217696,CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
167003,,5217704,CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.008
167004,,5217712,CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.008
167005,,5217720,CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.008
167006,,5217728,CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,2.0
167007,,5217736,CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.015
167008,,5217744,CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.5
167009,,5217752,CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.03
167010,,5217760,CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,64.0
167011,,5217768,CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,0.5
167012,,5217776,CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,1.0
167013,,5217784,CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.06
167014,,5217792,CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.015
167015,,5217800,CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.008
167016,,5217808,CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
167017,,5217816,CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,0.015
167018,,5217824,CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.03
167019,,5217832,CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,0.125
167020,,5217840,CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
167021,,5217848,CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC50,ug ml-1,UO_0000274,0.5
167022,,5217856,CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.06
167023,,5217864,CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,4.0
167024,,5217872,CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
167025,,5217880,CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,ug ml-1,UO_0000274,2.0
167026,,6172603,CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.07,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.07
167027,,6172612,CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.0003,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,0.0003
167028,,6172621,CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.007,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.007
167029,,6172630,CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.015
167030,,6172639,CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
167031,,6172648,CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.0
167032,,6172657,CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
167033,,6172666,CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.015
167034,,6172675,CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,50.0
167035,,6172684,CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.3
167036,,6172693,CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,100.0
167037,,6172702,CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
167038,,6172711,CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
167039,,6172720,CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
167040,,6172729,CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,MIC,ug.mL-1,0.07,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.07
167041,,6172738,CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC,ug ml-1,UO_0000274,100.0
167042,,6172748,CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,MIC,ug ml-1,UO_0000274,100.0
167043,,6173384,CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,ug ml-1,UO_0000274,100.0
167044,,6184803,CHEMBL1775350,Inhibition of wild-type Staphylococcus aureus topoisomerase 4-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,1422186,=,1,1,=,IC50,nM,400.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.4
167045,,6184810,CHEMBL1775351,Inhibition of wild-type Staphylococcus aureus DNA gyrase assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,1,http://www.openphacts.org/units/Nanomolar,1422186,=,1,1,=,IC50,nM,5600.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,5.6
167046,,6184817,CHEMBL1775357,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422186,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
167047,,6184824,CHEMBL1775519,Inhibition of Staphylococcus aureus topoisomerase 4 Ser80Phe mutant-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,1422186,=,1,1,=,IC50,nM,9800.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,9.8
167048,,6184831,CHEMBL1775520,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,1422186,>,1,1,>,IC50,nM,200000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,IC50,uM,UO_0000065,200.0
167049,,6184832,CHEMBL1775348,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422186,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167050,,6184833,CHEMBL1775353,Antibacterial activity against Escherichia coli ATCC25922 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1772978,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422186,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
167051,,6208971,CHEMBL1781603,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167052,,6208972,CHEMBL1781602,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-49,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167053,,6208973,CHEMBL1781604,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-52,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167054,,6208974,CHEMBL1781605,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
167055,,6208975,CHEMBL1781606,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 08-17,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
167056,,6208976,CHEMBL1781746,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 08-18,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
167057,,6208977,CHEMBL1781747,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
167058,,6208978,CHEMBL1781748,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 08-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167059,,6208979,CHEMBL1781749,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.06
167060,,6208980,CHEMBL1781750,Antibacterial activity against vancomycin-resistant Enterococcus faecalis EFL1004,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
167061,,6208981,CHEMBL1781751,Antibacterial activity against Streptococcus pyogenes 556,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.125
167062,,6208982,CHEMBL1781752,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
167063,,6208983,CHEMBL1781753,Antibacterial activity against Extended spectrum beta-lactamase producing Escherichia coli 08-5,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
167064,,6208984,CHEMBL1781754,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
167065,,6208985,CHEMBL1781755,Antibacterial activity against Pseudomonas aeruginosa 17,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
167066,,6208986,CHEMBL1781756,Antibacterial activity against Shigella sonnei 51592,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,0.03
167067,,6208987,CHEMBL1781757,Antibacterial activity against Bacillus typhi 50035,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.03
167068,,6208988,CHEMBL1781758,Antibacterial activity against Enterobacter cloacae 45301,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
167069,,6208989,CHEMBL1781759,Antibacterial activity against Acinetobacter calcoaceticus 25001,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.125
167070,,6208990,CHEMBL1781760,Antibacterial activity against Enterobacter aerogenes 45102,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
167071,,6208991,CHEMBL1781761,Antibacterial activity against Serratia marcescens 41002,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.125
167072,,6208992,CHEMBL1781762,Antibacterial activity against Morganella morganii 49086,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.06
167073,,6208993,CHEMBL1781763,Antibacterial activity against Proteus rettgeri 49006,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.06
167074,,6208994,CHEMBL1781764,Antibacterial activity against Proteus vulgaris 56,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.03
167075,,6228613,CHEMBL1785786,Cytotoxicity against MDCK cells after 48 hrs by CPE assay,A,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,1427622,=,1,1,=,CC50,nM,321000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,CC50,uM,UO_0000065,321.0
167076,,6229756,CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
167077,,6229757,CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
167078,,6229758,CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
167079,,6229759,CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
167080,,6229760,CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
167081,,6229761,CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167082,,6229762,CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
167083,,6229763,CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
167084,,6229764,CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
167085,,6229765,CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
167086,,6229766,CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
167087,,6229767,CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167088,,6229768,CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
167089,,6229769,CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
167090,,6229770,CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
167091,,6229771,CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
167092,,7975735,CHEMBL1929933,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
167093,,7975736,CHEMBL1929934,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
167094,,7975737,CHEMBL1929935,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167095,,7975738,CHEMBL1929936,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
167096,,7975739,CHEMBL1929937,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
167097,,7975740,CHEMBL1929938,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
167098,,7975741,CHEMBL1931190,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
167099,,7975742,CHEMBL1931191,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
167100,,7975743,CHEMBL1931192,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
167101,,7975744,CHEMBL1931193,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-5 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167102,,7975745,CHEMBL1931194,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-6 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
167103,,7975746,CHEMBL1931195,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
167104,,7975747,CHEMBL1931196,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
167105,,7975748,CHEMBL1931197,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
167106,,7975749,CHEMBL1931198,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
167107,,7975750,CHEMBL1931199,Antibacterial activity against Streptococcus pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.015
167108,,7975751,CHEMBL1931200,Antibacterial activity against Enterococcus faecium 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
167109,,7975752,CHEMBL1931201,Antibacterial activity against Enterococcus faecium 09-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
167110,,7975753,CHEMBL1931202,Antibacterial activity against Enterococcus faecium 09-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
167111,,7975754,CHEMBL1931203,Antibacterial activity against Enterococcus faecium 09-5 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
167112,,7975755,CHEMBL1931204,Antibacterial activity against Enterococcus faecium 09-6 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
167113,,7975756,CHEMBL1931205,Antibacterial activity against Enterococcus faecalis 09-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
167114,,7975757,CHEMBL1931206,Antibacterial activity against Enterococcus faecalis 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
167115,,7975758,CHEMBL1931207,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
167116,,7975759,CHEMBL1931208,Antibacterial activity against Escherichia coli 09-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167117,,7975760,CHEMBL1931209,Antibacterial activity against Escherichia coli 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
167118,,7975761,CHEMBL1931287,Antibacterial activity against Escherichia coli 09-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167119,,7975762,CHEMBL1929633,Antibacterial activity against Escherichia coli 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167120,,7975763,CHEMBL1929634,Antibacterial activity against Escherichia coli 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
167121,,7975764,CHEMBL1929635,Antibacterial activity against Escherichia coli 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
167122,,7975765,CHEMBL1929636,Antibacterial activity against Klebsiella pneumoniae 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
167123,,7975766,CHEMBL1929637,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.015
167124,,7975767,CHEMBL1929638,Antibacterial activity against Klebsiella pneumoniae 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
167125,,7975768,CHEMBL1929639,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
167126,,7975769,CHEMBL1929640,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
167127,,7975770,CHEMBL1929641,Antibacterial activity against Pseudomonas aeruginosa 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
167128,,7975771,CHEMBL1929642,Antibacterial activity against Pseudomonas aeruginosa 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
167129,,7975818,CHEMBL1929689,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,1563533,=,1,1,=,ED50,mg.kg-1,14.86,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,14.86
167130,,7975822,CHEMBL1929690,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-4 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,1563533,=,1,1,=,ED50,mg.kg-1,24.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,ED50,mg kg-1,UO_0000308,24.0
167131,,7975826,CHEMBL1929858,Antibacterial activity against Escherichia coli 10-2 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,1563533,=,1,1,=,ED50,mg.kg-1,6.86,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,6.86
167132,,7975830,CHEMBL1929859,Antibacterial activity against Klebsiella pneumoniae 10-3 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,1563533,=,1,1,=,ED50,mg.kg-1,108.46,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,ED50,mg kg-1,UO_0000308,108.46
167133,,7975834,CHEMBL1929860,Antibacterial activity against Pseudomonas aeruginosa 10-1 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,1563533,=,1,1,=,ED50,mg.kg-1,129.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,ED50,mg kg-1,UO_0000308,129.4
167134,,7977057,CHEMBL1929688,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
167135,,7977062,CHEMBL1929863,Antibacterial activity against Enterococcus faecium 09-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
167136,,10974515,CHEMBL2065876,Antimicrobial activity against Staphylococcus aureus ATCC 259223 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
167137,,10974540,CHEMBL2065877,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus aureus 10-11 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
167138,,10974565,CHEMBL2065878,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus aureus 10-15 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167139,,10974590,CHEMBL2065879,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus aureus 10-13 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
167140,,10974615,CHEMBL2065880,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus aureus 10-14 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
167141,,10974640,CHEMBL2065881,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus epidermidis 10-10 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
167142,,10974665,CHEMBL2065882,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus epidermidis 10-13 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
167143,,10974690,CHEMBL2065883,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus epidermidis 10-11 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
167144,,10974715,CHEMBL2065884,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus epidermidis 10-13 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
167145,,10975953,CHEMBL2065885,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus epidermidis 10-15 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
167146,,10975978,CHEMBL2065886,Antimicrobial activity against Enterococcus faecalis 10-5 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
167147,,10976003,CHEMBL2065887,Antimicrobial activity against Enterococcus faecalis 10-6 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
167148,,10976028,CHEMBL2065888,Antimicrobial activity against Enterococcus faecalis 10-7 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
167149,,10976053,CHEMBL2065889,Antimicrobial activity against Enterococcus faecium 10-5 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
167150,,10976078,CHEMBL2065890,Antimicrobial activity against Enterococcus faecium 10-9 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
167151,,10976103,CHEMBL2065891,Antimicrobial activity against extended spectrum beta-lactamases-producing Streptococcus pneumoniae 10-1 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167152,,10976128,CHEMBL2065892,Antimicrobial activity against extended spectrum beta-lactamases-producing Streptococcus pneumoniae 10-4 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167153,,10976153,CHEMBL2065893,Antimicrobial activity against Escherichia coli ATCC 25922 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
167154,,10976178,CHEMBL2065894,Antimicrobial activity against Escherichia coli 10-1 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
167155,,10976203,CHEMBL2065895,Antimicrobial activity against Escherichia coli 10-2 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
167156,,10977460,CHEMBL2065896,Antimicrobial activity against extended spectrum beta-lactamases-producing Escherichia coli 10-2 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167157,,10977485,CHEMBL2065897,Antimicrobial activity against Escherichia coli 10-3 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
167158,,10977510,CHEMBL2065898,Antimicrobial activity against extended spectrum beta-lactamases-producing Escherichia coli 10-3 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167159,,10977535,CHEMBL2065899,Antimicrobial activity against extended spectrum beta-lactamases-producing Escherichia coli 10-4 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
167160,,10977560,CHEMBL2065900,Antimicrobial activity against extended spectrum beta-lactamases-producing Klebsiella pneumoniae 10-1 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
167161,,10977585,CHEMBL2065901,Antimicrobial activity against Klebsiella pneumoniae 10-2 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
167162,,10977610,CHEMBL2065902,Antimicrobial activity against extended spectrum beta-lactamases-producing Klebsiella pneumoniae 10-2 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
167163,,10977635,CHEMBL2065903,Antimicrobial activity against Klebsiella pneumoniae 10-3 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
167164,,10977660,CHEMBL2065904,Antimicrobial activity against extended spectrum beta-lactamases-producing Klebsiella pneumoniae 10-3 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
167165,,10977685,CHEMBL2065905,Antimicrobial activity against Klebsiella pneumoniae 10-4 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
167166,,10977710,CHEMBL2065906,Antimicrobial activity against Pseudomonas aeruginosa 10-12 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.03
167167,,10977735,CHEMBL2065907,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-5 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
167168,,10978998,CHEMBL2065908,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-9 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
167169,,10979023,CHEMBL2066575,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-15 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
167170,,10979048,CHEMBL2066576,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-18 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
167171,,10979073,CHEMBL2066577,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-20 after 18-24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
167172,,10979076,CHEMBL2066578,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18-24 hrs by two-fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,2.0
167173,,10979079,CHEMBL2066578,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18-24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
167174,,10979081,CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.25
167175,,10979083,CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,8.0
167176,Not Determined,12070107,CHEMBL2162875,Cytotoxicity against human CHO cell line after 72 hrs,A,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,1732871,,1,0,,CC50,,,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,CC50,,,
167177,,12070118,CHEMBL2162874,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 5-FQR4M BSA678 expressing GyrA Ser84Leu and Ser85Pro mutant and GrlA Ser80Phe and Glu84Lys mutant,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167178,,12070129,CHEMBL2162873,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 4-FQR3M BSA643 expressing GyrA Ser84Leu mutant and GrlA Ser80Tyr and Glu84Gly mutant,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
167179,,12070140,CHEMBL2162872,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 3-FQR3M ATCC 700699 expressing GyrA Ser84Leu mutant and Glu409Lys mutant and GrlA Ser80Phe mutant,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
167180,,12070151,CHEMBL2162871,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 2-FQR2M NY2746 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
167181,,12070162,CHEMBL2162870,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 1-FQR2M BK2384 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167182,,12070194,CHEMBL2161980,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,1732871,=,1,1,=,IC50,nM,400.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.4
167183,,12070215,CHEMBL2161979,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,1,http://www.openphacts.org/units/Nanomolar,1732871,=,1,1,=,IC50,nM,5600.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,5.6
167184,,12070236,CHEMBL2161978,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
167185,,12070257,CHEMBL2161977,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2157972,J Med Chem,2011.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167186,,12532090,CHEMBL3077737,Antitubercular activity against Mycobacterium tuberculosis,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL3046014,Med Chem Res,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825951,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,8.0
167187,,12644245,CHEMBL2330399,Antibacterial activity against Chlamydophila pneumoniae CM-1 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2321831,J Med Chem,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,MIC,ug ml-1,UO_0000274,0.063
167188,,12644246,CHEMBL2330400,Antibacterial activity against Chlamydophila pneumoniae AR39 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2321831,J Med Chem,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,MIC,ug ml-1,UO_0000274,0.125
167189,,12644247,CHEMBL2330401,Antibacterial activity against Mycoplasma pneumoniae ATCC 29085 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2321831,J Med Chem,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
167190,,12644248,CHEMBL2330402,Antibacterial activity against Mycoplasma pneumoniae 18-1 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2321831,J Med Chem,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
167191,,12676114,CHEMBL2344267,Antibacterial activity against Staphylococcus aureus ATCC 259233,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
167192,,12676170,CHEMBL2346118,Antibacterial activity against Pseudomonas aeruginosa isolate 12-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
167193,,12678617,CHEMBL2344247,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli isolate 12-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167194,,12678619,CHEMBL2344249,Antibacterial activity against Escherichia coli isolate 12-5,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167195,,12678620,CHEMBL2344250,Antibacterial activity against Escherichia coli isolate 12-4,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
167196,,12678634,CHEMBL2346119,Antibacterial activity against Pseudomonas aeruginosa isolate 12-1,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
167197,,12678652,CHEMBL2344248,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli isolate 12-1,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
167198,,12678693,CHEMBL2344256,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 12-33,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
167199,,12678703,CHEMBL2344265,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate 12-7,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
167200,,12678706,CHEMBL2346121,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolate 12-4,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
167201,,12678708,CHEMBL2346122,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolate 12-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
167202,,12678710,CHEMBL2346123,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolate 12-1,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
167203,,12678724,CHEMBL2344246,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli isolate 12-4,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167204,,12678748,CHEMBL2346120,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
167205,,12681509,CHEMBL2344253,Antibacterial activity against Streptococcus pneumoniae isolate 12-5,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167206,,12681511,CHEMBL2344254,Antibacterial activity against Streptococcus pneumoniae isolate 12-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167207,,12681526,CHEMBL2344259,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate 12-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
167208,,12681565,CHEMBL2344251,Antibacterial activity against Escherichia coli isolate 12-1,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
167209,,12681596,CHEMBL2346124,Antibacterial activity against Klebsiella pneumoniae isolate 12-4,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
167210,,12681598,CHEMBL2346125,Antibacterial activity against Klebsiella pneumoniae isolate 12-2,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
167211,,12681608,CHEMBL2344258,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate 12-3,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
167212,,12681610,CHEMBL2344260,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate 12-1,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
167213,,12681621,CHEMBL2346126,Antibacterial activity against Klebsiella pneumoniae isolate 12-1,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
167214,,12681623,CHEMBL2344261,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 12-15,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167215,,12681626,CHEMBL2344263,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 12-3,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167216,,12681628,CHEMBL2344264,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate 12-10,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167217,,12681631,CHEMBL2344266,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate 12-6,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
167218,,12681635,CHEMBL2344252,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
167219,,12681642,CHEMBL2344257,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 12-5,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.015
167220,,12681645,CHEMBL2344262,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 12-13,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
167221,,12681647,CHEMBL2344255,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 12-35,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.008
167222,,19051585,CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,mg/L,UO_0000274,4.0
167223,,19051599,CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,mg/L,UO_0000274,0.03
167224,,19051611,CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612535,Klebsiella,Klebsiella,570.0,,MIC90,mg/L,UO_0000274,0.25
167225,Not Determined,19051625,CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,3178406,,1,0,,MIC90,,,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,,,
167226,,19051639,CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,mg/L,UO_0000274,0.06
167227,,19051653,CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,0.06
167228,,19051667,CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,0.03
167229,,19051681,CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,mg/L,UO_0000274,0.06
167230,,19051695,CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,mg/L,UO_0000274,4.0
167231,Not Determined,19051709,CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,3178406,,1,0,,MIC90,,,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,,,
167232,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051764,CHEMBL4355007,"Cmax in human at 0.32 g, po",A,BAO_0002119,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,3178406,=,1,1,=,Cmax,nM,2568.12,CHEMBL612558,,ADMET,,,Cmax,mg/L,UO_0000065,1.0
167233,,19051765,CHEMBL4355008,"AUC in human at 0.32 g, po",A,BAO_0002120,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,,3178406,=,1,1,=,AUC,ng.hr.mL-1,9000.0,CHEMBL612558,,ADMET,,,AUC,mg.hr/L,,9.0
167234,,19051766,CHEMBL4355009,"Half life in human at 0.32 g, po",A,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://qudt.org/vocab/unit#Hour,3178406,=,1,1,=,T1/2,hr,7.0,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,7.0
167235,,19957097,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4495564,,2020.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://qudt.org/vocab/unit#Percent,3343515,=,52,1,=,Inhibition,%,16.45,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,16.45
167236,,20150102,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4495565,,2020.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://qudt.org/vocab/unit#Percent,3361387,=,52,1,=,Inhibition,%,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.09
167237,,22072877,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL4495565,,2020.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://qudt.org/vocab/unit#Percent,3361387,=,52,1,=,Inhibition,%,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.09
167238,,24837165,CHEMBL5144782,Antibacterial activity against rifampicin resistant Staphylococcus aureus harboring RpoBH481Y mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.016
167239,,24837200,CHEMBL5144783,Antibacterial activity against wild type Staphylococcus aureus assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.016
167240,,24837235,CHEMBL5144784,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus harboring ParCS80F and GyrAS84L double mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167241,,24837270,CHEMBL5144785,Antibacterial activity against Staphylococcus aureus harboring RpoBH481Y/ParCS80F/GyrAS84L triple mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167242,,24837305,CHEMBL5144786,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,MIC,ug.mL-1,0.0078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0078
167243,,25040727,CHEMBL5244791,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Alamar blue staining based analysis,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922853,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
167244,,25040749,CHEMBL5244793,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922853,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
167245,,25041327,CHEMBL5244894,Antibacterial activity against clinical isolate Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3923178,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
167246,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207886,CHEMBL5291800,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by scintillation counting,B,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,CHEMBL5291721,Nat Commun,2023.0,CHEMBL430,GEMIFLOXACIN,CHEMBL430,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,AC50,nM,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,30.0
167247,,43133,CHEMBL760396,Minimum inhibitory concentration against Pasteurella multocida,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144360,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,MIC,ug ml-1,UO_0000274,0.1
167248,,43134,CHEMBL682927,Minimum inhibitory concentration against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144360,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.56
167249,,43135,CHEMBL814224,Minimum inhibitory concentration against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144360,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
167250,,43136,CHEMBL813000,Effective dose required to inhibit Staphylococcus aureus intraperitoneal (IP) infection model,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,144360,=,1,1,=,ED50,mg.kg-1,4.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,4.1
167251,,66318,CHEMBL795180,Minimum inhibitory concentration against Staphylococcus aureus 10649 (erythromycin susceptible strain),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134286,J Med Chem,2001.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,255107,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
167252,,66320,CHEMBL812546,Minimum inhibitory concentration against Streptococcus pneumoniae 6303 (erythromycin susceptible strain),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134286,J Med Chem,2001.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,255107,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
167253,,66322,CHEMBL809733,Cell free inhibiting activity against Streptococcus pneumoniae 5635(Wild type ribosomes for transcription/translation assay),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134286,J Med Chem,2001.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,255107,=,1,1,=,IC50,nM,170.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,0.17
167254,,66323,CHEMBL809732,Cell free inhibiting activity against Streptococcus pneumoniae 1813 (methylated ribosomes for transcription/translation assay),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1134286,J Med Chem,2001.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,255107,>,1,1,>,IC50,nM,500000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,500.0
167255,,243639,CHEMBL859379,Minimum inhibitory concentration required for antibacterial activity against Enterococcus faecalis MB 5407 strain;value ranges from 4-8,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
167256,,243640,CHEMBL856960,Minimum inhibitory concentration required for antibacterial activity against Staphylococcus aureus MB 2865 strain;value ranges from 0.5-1,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167257,,243641,CHEMBL807176,Minimum inhibitory concentration required for antibacterial activity against Staphylococcus epidermidis MB 5414 strain;value ranges from 0.25-0.5,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
167258,,243642,CHEMBL812378,Minimum inhibitory concentration required for antibacterial activity against Streptococcus pneumoniae CL 2883 strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
167259,,243643,CHEMBL809199,Minimum inhibitory concentration required for antibacterial activity against Streptococcus pyogenes MB 2874 strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
167260,,243644,CHEMBL677361,Minimum inhibitory concentration required for antibacterial activity against Enterobacter cloacae CL 4298 strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,1.0
167261,,243645,CHEMBL678938,Minimum inhibitory concentration required for antibacterial activity against Escherichia coli MB 2884 strain;value ranges from 1-2,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
167262,,243646,CHEMBL695874,Minimum inhibitory concentration required for antibacterial activity against Haemophilus influenzae MB 5363 strain;value ranges from 0.5-2,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
167263,,243647,CHEMBL695869,Minimum inhibitory concentration required for antibacterial activity against Haemophilus influenzae CL 1830 strain;value ranges from 8-16,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,8.0
167264,,243648,CHEMBL873319,Minimum inhibitory concentration required for antibacterial activity against Klebsiella pneumoniae MB 4005 strain;value ranges from 1-2,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
167265,,246631,CHEMBL810381,The compound has been evaluated for the antibacterial activity against Staphylococcus aureus EryS 011UC4 strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.3
167266,,246632,CHEMBL810380,The compound has been evaluated for the antibacterial activity against Staphylococcus aureus EryRi 011GO25i strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
167267,,246633,CHEMBL811530,The compound has been evaluated for the antibacterial activity against Staphylococcus aureus EryRc 011CB20 strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
167268,,246634,CHEMBL809706,The compound has been evaluated for the antibacterial activity against Streptococcus pyogenes EryS 02A1UC1.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.6
167269,,246635,CHEMBL811337,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae EryS 032UC1 strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.15
167270,,246636,CHEMBL814206,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae EryRc 030PW23c strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167271,,246637,CHEMBL814207,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae EryRc 030SJ1 strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167272,,246638,CHEMBL814205,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae Ery Ri 030SJ 5i strains,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167273,,246639,CHEMBL689728,The compound has been evaluated for the antibacterial activity against Haemophilus influenzae 351HT3 (beta-lactamase +),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,MIC,ug.mL-1,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.2
167274,,447151,CHEMBL807891,In vitro inhibitory activity against Staphylococcus aureus (011UC4),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.3
167275,,447152,CHEMBL810579,In vitro inhibitory activity against Staphylococcus aureus (EryRi 011GO25i),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
167276,,447153,CHEMBL805299,In vitro inhibitory activity against Staphylococcus epidermidis (EryRi 012GO11i),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,40.0
167277,,447154,CHEMBL883637,In vitro inhibitory activity against Staphylococcus aureus (EryRc 011CB20),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
167278,,447155,CHEMBL812248,In vitro inhibitory activity against Streptococcus pneumoniae (EryRc 030SJ1),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167279,,447156,CHEMBL812249,In vitro inhibitory activity against Streptococcus pneumoniae (EryRi 030SJ5i),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167280,,447157,CHEMBL812247,In vitro inhibitory activity against Streptococcus pneumoniae (032UC1),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.15
167281,,447158,CHEMBL813823,In vitro inhibitory activity against Streptococcus pyogenes (02A1UC1),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.6
167282,,447159,CHEMBL690185,In vitro inhibitory activity against Haemophilus influenzae (351HT3),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.2
167283,,447160,CHEMBL690184,In vitro inhibitory activity against Haemophilus influenzae (351CB12),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.2
167284,,447161,CHEMBL683029,In vitro inhibitory activity against Escherichia coli (250 UC5),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC,ug.mL-1,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,20.0
167285,,447162,CHEMBL807026,In vitro inhibitory activity against Staphylococci EryRi (65),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,,1,1,,MIC50,ug.mL-1,40.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC50,ug ml-1,UO_0000274,40.0
167286,,447163,CHEMBL809795,In vitro inhibitory activity against Staphylococci EryRi (65),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC90,ug ml-1,UO_0000274,40.0
167287,Not Determined,447164,CHEMBL807025,In vitro inhibitory activity against Staphylococci EryRc (23);ND=not determined,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,,1,0,,MIC50,ug.mL-1,,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC50,ug ml-1,UO_0000274,
167288,Not Determined,447165,CHEMBL809794,In vitro inhibitory activity against Staphylococci EryRc (23);ND=not determined,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,,1,0,,MIC90,ug.mL-1,,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC90,ug ml-1,UO_0000274,
167289,,447166,CHEMBL678986,In vitro inhibitory activity against enterococci EryRi (19),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,40.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC50,ug ml-1,UO_0000274,40.0
167290,,447167,CHEMBL678460,In vitro inhibitory activity against enterococci EryRi (19),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,ug ml-1,UO_0000274,40.0
167291,,447168,CHEMBL678983,In vitro inhibitory activity against enterococci EryRc (13),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,10.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC50,ug ml-1,UO_0000274,10.0
167292,,447169,CHEMBL679162,In vitro inhibitory activity against enterococci EryRc (13),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,ug ml-1,UO_0000274,40.0
167293,,447170,CHEMBL805504,In vitro inhibitory activity against Streptococci EryR (27),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,10.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,10.0
167294,,447171,CHEMBL806145,In vitro inhibitory activity against Streptococci EryR (27),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,40.0
167295,,447172,CHEMBL805507,In vitro inhibitory activity against Streptococci EryRi (98),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,40.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,40.0
167296,,447173,CHEMBL805375,In vitro inhibitory activity against Streptococci EryRi (98),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,40.0
167297,,447174,CHEMBL766974,In vitro inhibitory activity against Pneumococci EryRc (34),F,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,40.0,CHEMBL612545,,Unchecked,,,MIC50,ug ml-1,UO_0000274,40.0
167298,,447175,CHEMBL877859,In vitro inhibitory activity against Pneumococci EryRc (34),F,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL612545,,Unchecked,,,MIC90,ug ml-1,UO_0000274,40.0
167299,,447176,CHEMBL766976,In vitro inhibitory activity against Pneumococci PenR (65),F,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,2.5,CHEMBL612545,,Unchecked,,,MIC50,ug ml-1,UO_0000274,2.5
167300,,447177,CHEMBL766982,In vitro inhibitory activity against Pneumococci PenR (65),F,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,40.0,CHEMBL612545,,Unchecked,,,MIC90,ug ml-1,UO_0000274,40.0
167301,,447178,CHEMBL695046,In vitro inhibitory activity against Haemophilus AmpS (43),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,0.15,CHEMBL614407,Haemophilus,Haemophilus,724.0,,MIC50,ug ml-1,UO_0000274,0.15
167302,,447179,CHEMBL689956,In vitro inhibitory activity against Haemophilus AmpS (43),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,1.2,CHEMBL614407,Haemophilus,Haemophilus,724.0,,MIC90,ug ml-1,UO_0000274,1.2
167303,,447180,CHEMBL695045,In vitro inhibitory activity against Haemophilus AmpR (37),F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC50,ug.mL-1,0.3,CHEMBL614407,Haemophilus,Haemophilus,724.0,,MIC50,ug ml-1,UO_0000274,0.3
167304,,447181,CHEMBL692891,In vitro inhibitory activity against Haemophilus AmpR (37),F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,MIC90,ug.mL-1,1.2,CHEMBL614407,Haemophilus,Haemophilus,724.0,,MIC90,ug ml-1,UO_0000274,1.2
167305,,447182,CHEMBL813002,In Vivo evaluation for its effective dose against Staphylococcus aureus (011UC4). ,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,=,1,1,=,ED50,mg.kg-1,60.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,60.0
167306,,447183,CHEMBL813001,In Vivo evaluation for its effective dose against Staphylococcus aureus (011GO25 EryRi.,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,100.0
167307,,447184,CHEMBL809716,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (032UC1),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,50.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,50.0
167308,,447185,CHEMBL809657,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030RO1 EryRi),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
167309,,447186,CHEMBL809659,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030SJ6 EryRc),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
167310,,447187,CHEMBL809656,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030MV2 EryRc),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
167311,,447188,CHEMBL809658,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030SJ1 EryRc),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
167312,,447189,CHEMBL809655,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030Cr29 EryRc),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
167313,,447190,CHEMBL808174,In Vivo evaluation for its effective dose against Streptococcus pyogenes (02A1UC1),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,=,1,1,=,ED50,mg.kg-1,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,ED50,mg kg-1,UO_0000308,16.0
167314,,447191,CHEMBL694440,In Vivo evaluation for its effective dose against Haemophilus influenzae (351GR1),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,=,1,1,=,ED50,mg.kg-1,109.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,ED50,mg kg-1,UO_0000308,109.0
167315,,447192,CHEMBL699399,In Vivo evaluation for its effective dose against Haemophilus influenzae (351TO19 AmpR beta (-)),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,=,1,1,=,ED50,mg.kg-1,368.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,ED50,mg kg-1,UO_0000308,368.0
167316,,447193,CHEMBL694439,In Vivo evaluation for its effective dose against Haemophilus influenzae (351RD7 AmpR beta (+)),F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131139,J Med Chem,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,252675,=,1,1,=,ED50,mg.kg-1,117.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,ED50,mg kg-1,UO_0000308,117.0
167317,,458191,CHEMBL813783,Compound was evaluated for antibacterial activity against Streptococcus pneumoniae (MB3957) sensitive strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,<,1,1,<,MIC,ug.mL-1,60.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg ml-1,UO_0000274,0.06
167318,,458192,CHEMBL808955,Compound was evaluated for antibacterial activity against Streptococcus pyogenes (MB2874) sensitive strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,MIC,ug.mL-1,30.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,mg ml-1,UO_0000274,0.03
167319,,458193,CHEMBL807854,Compound was evaluated for antibacterial activity against Staphylococcus aureus (MB2865) sensitive strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg ml-1,UO_0000274,0.5
167320,,458194,CHEMBL679800,Compound was evaluated for antibacterial activity against Enterococcus faecalis (MB5407) sensitive strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,MIC,ug.mL-1,4000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg ml-1,UO_0000274,4.0
167321,,458195,CHEMBL673987,Compound was evaluated for antibacterial activity against Enterococcus faecium (MB5516) sensitive strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,mg ml-1,UO_0000274,0.25
167322,,458196,CHEMBL651891,Compound was evaluated for antibacterial activity against Bacillus subtilis (MB5586) sensitive strain,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,MIC,ug.mL-1,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,mg ml-1,UO_0000274,1.0
167323,,464909,CHEMBL624569,Observed volume of distribution,A,BAO_0003041,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1148291,J Med Chem,2004.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,29106,=,1,1,=,Vdss,L.kg-1,33.0,CHEMBL612558,,ADMET,,,Vdss,l kg-1,UO_0000197,33.0
167324,,464910,CHEMBL618310,Unbound fraction (plasma),A,BAO_0000179,BAO_0000366,cell-free format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1148291,J Med Chem,2004.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,29106,=,1,1,=,Fu,,0.88,CHEMBL612558,,ADMET,,,Fu,,,0.88
167325,,485070,CHEMBL745309,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium avium complex (MAC) ATCC 49601,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129577,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,4.0
167326,,485071,CHEMBL744960,Compound was evaluated for in vitro anti-mycobacterial activity against MAC 101,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129577,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,4.0
167327,,485072,CHEMBL751648,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium simiae,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129577,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614988,Mycobacterium simiae,Mycobacterium simiae,1784.0,,MIC,ug ml-1,UO_0000274,4.0
167328,,485073,CHEMBL752461,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium xenopi,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129577,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612642,Mycobacterium xenopi,Mycobacterium xenopi,1789.0,,MIC,ug ml-1,UO_0000274,1.0
167329,,485074,CHEMBL751367,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium malmoense,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129577,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL613090,Mycobacterium malmoense,Mycobacterium malmoense,1780.0,,MIC,ug ml-1,UO_0000274,16.0
167330,,485075,CHEMBL748682,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium fortuitum,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129577,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,ug ml-1,UO_0000274,64.0
167331,,726086,CHEMBL878287,In vitro minimum inhibitory concentration against Enterococcus faecalis MB5407.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
167332,,726087,CHEMBL814109,In vitro minimum inhibitory concentration against Staphylococcus aureus MB2865.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167333,,726088,CHEMBL808408,In vitro minimum inhibitory concentration against Streptococcus pneumoniae CL2883.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167334,,726089,CHEMBL680447,In vitro minimum inhibitory concentration against Escherichia coli MB2884.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
167335,,726090,CHEMBL694347,In vitro minimum inhibitory concentration against Haemophilus influenzae MB5363.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
167336,,726091,CHEMBL702479,In vitro minimum inhibitory concentration against Klebsiella pneumoniae MB4005.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
167337,,843291,CHEMBL808931,The compound was tested in vitro for antibacterial activity against erythromycin susceptible Staphylococcus aureus 011UC4,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.3
167338,,843292,CHEMBL808933,The compound was tested in vitro for antibacterial activity against inducibly erythromycin resistant Staphylococcus aureus 011GO25i,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
167339,,843293,CHEMBL810474,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Staphylococcus aureus 011CB20,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
167340,,843294,CHEMBL809711,The compound was tested in vitro for antibacterial activity against erythromycin susceptible Streptococcus pyogenes 02A1UC1,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.6
167341,,843295,CHEMBL857923,The compound was tested in vitro for antibacterial activity against erythromycin susceptible Streptococcus pneumoniae 032UC1,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.15
167342,,843296,CHEMBL809209,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030PW23c,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167343,,843297,CHEMBL809207,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030CR18c,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167344,,843298,CHEMBL809211,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030SJ1,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167345,,843299,CHEMBL814666,The compound was tested in vitro for antibacterial activity against inducibly erythromycin resistant Streptococcus pneumoniae 030J5i,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167346,,843300,CHEMBL690594,The compound was tested in vitro for antibacterial activity against Haemophilus influenza 351HT3,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.2
167347,,843301,CHEMBL673725,The compound was tested in vitro for antibacterial activity against Escherichia coli 250 UCS,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,MIC,ug.mL-1,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,20.0
167348,Active,889293,CHEMBL694438,Antibacterial activity against Haemophilus influenzae; Active,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,241418,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167349,Active,889294,CHEMBL707895,Antibacterial activity against Legionella; More active,F,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,241418,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
167350,Active,889295,CHEMBL876527,Antibacterial activity against Brahmella species.; More active,F,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,241418,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
167351,Active,889296,CHEMBL661476,Antibacterial activity against Chlamydia; More active,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,241418,,1,0,,Activity,,,CHEMBL614410,Chlamydia,Chlamydia,810.0,,Activity,,,
167352,Active,889297,CHEMBL761253,Antibacterial activity against Pasteurella multocida; More active,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,241418,,1,0,,Activity,,,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,Activity,,,
167353,Active,889298,CHEMBL805376,Antibacterial activity against Streptococci; More active,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,241418,,1,0,,Activity,,,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,Activity,,,
167354,,894771,CHEMBL857238,Minimum inhibitory concentration against macrolide susceptible strain of Streptococcus pneumoniae (MB3957),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,<,1,1,<,MIC,ug.mL-1,60.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg ml-1,UO_0000274,0.06
167355,,894772,CHEMBL809184,Minimum inhibitory concentration against macrolide susceptible strain of Streptococcus pyogenes (MB2874),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,MIC,ug.mL-1,30.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,mg ml-1,UO_0000274,0.03
167356,,894773,CHEMBL812137,Minimum inhibitory concentration against macrolide susceptible strain of Staphylococcus aureus (MB2865),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg ml-1,UO_0000274,0.5
167357,,894774,CHEMBL678979,Minimum inhibitory concentration against macrolide susceptible strain of Enterococcus faecalis (MB5407),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,MIC,ug.mL-1,4000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg ml-1,UO_0000274,4.0
167358,,894775,CHEMBL878280,Minimum inhibitory concentration against macrolide susceptible strain of Enterococcus faecium (MB5516),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,mg ml-1,UO_0000274,0.25
167359,,894776,CHEMBL650971,Minimum inhibitory concentration against macrolide susceptible strains of Bacillus subtilis (MB5586),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,MIC,ug.mL-1,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,mg ml-1,UO_0000274,1.0
167360,,894777,CHEMBL748702,Minimum inhibitory concentration against macrolide susceptible strains of Mycobacterium smegmatis (MC2155),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,MIC,ug.mL-1,4000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,mg ml-1,UO_0000274,4.0
167361,,927449,CHEMBL760551,Minimum inhibitory concentration against Pasteurella multocida,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130001,J Med Chem,1997.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,39517,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,MIC,ug ml-1,UO_0000274,0.05
167362,,972961,CHEMBL801146,In vitro minimum inhibitory concentration for antibacterial activity against erythromycin-susceptible strain Staphylococcus aureus 209-JC,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.39
167363,,972962,CHEMBL801165,In vitro minimum inhibitory concentration for antibacterial activity against Staphylococcus aureus B1 (inducibly MLSb-resistant strain encoded by the erm(C) gene),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
167364,,972963,CHEMBL807557,In vitro minimum inhibitory concentration for antibacterial activity against Staphylococcus aureus SR138 (constitutively MLSb-resistant strain encoded by the erm(A) gene),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
167365,,972964,CHEMBL804724,In vitro minimum inhibitory concentration for antibacterial activity against erythromycin-susceptible strain Streptococcus pneumoniae IID553,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.1
167366,,972965,CHEMBL807111,In vitro minimum inhibitory concentration for antibacterial activity against Streptococcus pneumoniae 210 (efflux-resistant strain encoded by the mef(A) gene),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.78
167367,,972966,CHEMBL807112,In vitro minimum inhibitory concentration for antibacterial activity against Streptococcus pneumoniae 211 (MLSb-resistant strain encoded by the erm(B) gene),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,100.0
167368,,972967,CHEMBL688892,In vitro minimum inhibitory concentration for antibacterial activity against Haemophilus influenzae ATCC 43095 (ampicillin-susceptible strain that does not produce beta-lactamase),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.56
167369,,972968,CHEMBL688891,In vitro minimum inhibitory concentration for antibacterial activity against Haemophilus influenzae ATCC 33533 (ampicillin-resistant strain that produces beta-lactamase),F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.56
167370,,972969,CHEMBL807558,In vitro minimum inhibitory concentration for antibacterial activity against erythromycin susceptible strain Staphylococcus aureus Smith,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
167371,,972971,CHEMBL804723,In vitro minimum inhibitory concentration for antibacterial activity against erythromycin susceptible strain Streptococcus pneumoniae IID553,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145811,J Med Chem,2003.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167634,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.1
167372,,1048644,CHEMBL808661,In vivo antibacterial activity against Staphylococcus aureus strain 10649,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5554,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
167373,,1048645,CHEMBL813005,In vivo antibacterial activity against Staphylococcus aureus strain 10649,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,5554,=,1,1,=,ED50,mg.kg-1,24.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,24.8
167374,,1048646,CHEMBL814165,In vivo antibacterial activity against Streptococcus pneumoniae strain 6303,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5554,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
167375,,1048647,CHEMBL809719,In vivo antibacterial activity against Streptococcus pneumoniae strain 6303,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,5554,=,1,1,=,ED50,mg.kg-1,18.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,18.8
167376,,1048648,CHEMBL814821,In vivo antibacterial activity against Streptococcus pyogenes strain C203,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5554,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
167377,,1048649,CHEMBL809948,In vivo antibacterial activity against Streptococcus pyogenes strain C203,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,5554,=,1,1,=,ED50,mg.kg-1,6.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,ED50,mg kg-1,UO_0000308,6.1
167378,,1048650,CHEMBL814821,In vivo antibacterial activity against Streptococcus pyogenes strain C203,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5554,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
167379,,1048651,CHEMBL809719,In vivo antibacterial activity against Streptococcus pneumoniae strain 6303,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,5554,=,1,1,=,ED50,mg.kg-1,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,6.0
167380,,1048652,CHEMBL814164,In vivo antibacterial activity against Streptococcus pneumoniae strain 5649,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5554,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
167381,,1048653,CHEMBL809718,In vivo antibacterial activity against Streptococcus pneumoniae strain 5649,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,5554,=,1,1,=,ED50,mg.kg-1,78.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,78.7
167382,,1048654,CHEMBL814166,In vivo antibacterial activity against Streptococcus pneumoniae strain 6396,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5554,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167383,,1048655,CHEMBL809720,In vivo antibacterial activity against Streptococcus pneumoniae strain 6396,F,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1132973,J Med Chem,2000.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,5554,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
167384,,1084001,CHEMBL760394,Minimum inhibitory concentration required to inhibit Pasteurella multocida 59A006 in vitro,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130408,J Med Chem,1997.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5006,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,MIC,ug ml-1,UO_0000274,0.05
167385,,1265069,CHEMBL809630,Compound was tested for antibacterial activity against Staphylococcus aureus 011UC4 using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.3
167386,,1265070,CHEMBL808382,Compound was tested for antibacterial activity against Streptococcus pneumoniae 030SJ1 EryRc using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167387,,1265071,CHEMBL810955,Compound was tested for antibacterial activity against Streptococcus pneumoniae 030SJ5i EryRi using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,40.0
167388,,1265072,CHEMBL810956,Compound was tested for antibacterial activity against Streptococcus pneumoniae 032UC1 using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.15
167389,,1265073,CHEMBL810789,Compound was tested for antibacterial activity against Streptococcus pyogenes 02A1UC1 using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.6
167390,,1265074,CHEMBL696265,Compound was tested for antibacterial activity against Haemophilus influenzae 351HT3 using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.2
167391,,1265075,CHEMBL676167,Compound was tested for antibacterial activity against Escherichia coli 250 UC5 using standard broth microdilution assay.,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1130953,Bioorg Med Chem Lett,1998.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144336,=,1,1,=,MIC,ug.mL-1,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,20.0
167392,,1423918,CHEMBL830612,Minimum inhibitory concentration of compound against Ery-S Staphylococcus aureus ATCC 23029 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167393,,1423919,CHEMBL831788,Minimum inhibitory concentration of compound against Ery-R Streptococcus pyogenes 3262 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167394,,1423920,CHEMBL831785,Minimum inhibitory concentration of compound against Ery-R Streptococcus pyogenes 1721 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167395,,1423921,CHEMBL830509,Minimum inhibitory concentration of compound against Ery-S Streptococcus pneumoniae 3773 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167396,,1423922,CHEMBL830508,Minimum inhibitory concentration of compound against Ery-R Streptococcus pneumoniae 5032 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167397,,1423923,CHEMBL830507,Minimum inhibitory concentration of compound against Ery-R Staphylococcus aureus 96:11480 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167398,,1423924,CHEMBL830687,Minimum inhibitory concentration of compound against Ery-S Streptococcus pyogenes ATCC 19615 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.125
167399,,1423925,CHEMBL830499,Minimum inhibitory concentration of compound against Ery-R Streptococcus pyogenes 13029 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167400,,1423926,CHEMBL830711,Minimum inhibitory concentration of compound against Ery-S Streptococcus pneumoniae ATCC 49619 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
167401,,1424033,CHEMBL830498,Minimum inhibitory concentration of compound against Ery-R Streptococcus pneumoniae 163 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167402,,1424034,CHEMBL875744,Minimum inhibitory concentration of compound against Ery-R Streptococcus pneumoniae 303 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167403,,1424035,CHEMBL830710,Minimum inhibitory concentration of compound against Ery-S Haemophilus influenzae ATCC 49247 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,4.0
167404,,1424036,CHEMBL831786,Minimum inhibitory concentration of compound against Ery-R Streptococcus pyogenes 1850 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1141993,Bioorg Med Chem Lett,2005.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,366169,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167405,,1828469,CHEMBL909145,Antimicrobial activity against Naegleria fowleri Lee (M67) at day 3,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142142,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,625608,=,1,1,=,IC50,nM,3.1,CHEMBL3301413,Naegleria fowleri,Naegleria fowleri,5763.0,,IC50,nM,UO_0000065,3.1
167406,,1828477,CHEMBL909144,Antimicrobial activity against Naegleria fowleri Lee (M67) at day 2,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142142,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,625608,=,1,1,=,IC50,nM,2.6,CHEMBL3301413,Naegleria fowleri,Naegleria fowleri,5763.0,,IC50,nM,UO_0000065,2.6
167407,,1828958,CHEMBL908126,Cytotoxicity against primary human osteoblasts at 100 ug/ml assessed as LDH release after 24 hrs,A,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,625762,=,1,0,=,Activity,%,20.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,20.0
167408,,1829110,CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625762,=,1,1,=,IC50,ug.mL-1,25.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,ug ml-1,UO_0000274,25.0
167409,,1829120,CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625762,=,1,1,=,IC50,ug.mL-1,160.0,CHEMBL612582,,Osteoblast,,,IC50,ug ml-1,UO_0000274,160.0
167410,,1832421,CHEMBL911423,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from deployed military patient,F,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625557,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,8.0
167411,,1832422,CHEMBL911423,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from deployed military patient,F,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625557,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
167412,,1832437,CHEMBL911424,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from nondeployed military patient,F,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625557,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
167413,,1832438,CHEMBL911424,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from nondeployed military patient,F,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625557,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,8.0
167414,,1833749,CHEMBL909813,Inhibition of Plasmodium falciparum in HRP2 ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142189,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625888,=,1,1,=,IC50,ug.mL-1,2.57,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,2570.28
167415,,1833764,CHEMBL909814,Inhibition of Plasmodium falciparum AZ10011003 isolate in HRP2 ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142189,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625888,=,1,1,=,IC50,ug.mL-1,2.444,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,2443.97
167416,,1833765,CHEMBL909815,Inhibition of Plasmodium falciparum AZ10011008 isolate in HRP2 ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142189,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625888,=,1,1,=,IC50,ug.mL-1,5.342,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,5342.33
167417,,1833766,CHEMBL909816,Inhibition of Plasmodium falciparum AZ10011017 isolate in HRP2 ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142189,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625888,=,1,1,=,IC50,ug.mL-1,1.976,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,1976.38
167418,,1833767,CHEMBL909817,Inhibition of Plasmodium falciparum AZ10011022 isolate in HRP2 ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142189,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625888,=,1,1,=,IC50,ug.mL-1,2.19,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,2190.46
167419,,1834937,CHEMBL906974,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 1077 with 23S rRNA A2058G mutation after 29 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167420,,1834943,CHEMBL906980,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 3243 with L22 insertion 93SFRPRA94 mutation after 33 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167421,,1834948,CHEMBL908692,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 2527 after 20 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167422,,1834969,CHEMBL908694,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81Y and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167423,,1834981,CHEMBL908695,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167424,,1834998,CHEMBL908696,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81F and ParC D83N mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167425,,1835016,CHEMBL908697,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167426,,1835047,CHEMBL908698,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167427,,1835061,CHEMBL908699,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167428,,1835074,CHEMBL908700,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 1077 with 23S rRNA A2058G mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167429,,1835088,CHEMBL908701,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3665 with GyrA S81Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167430,,1835098,CHEMBL908702,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3665 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167431,,1835117,CHEMBL908703,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3676 with GyrA E85G, GyrB S478I and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167432,,1835139,CHEMBL908704,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3676 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
167433,,1835149,CHEMBL908705,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3243 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167434,,1835159,CHEMBL908706,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 3243 with L22 insertion 93SFRPRA94 mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
167435,,1835169,CHEMBL908707,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3243 with 23S rRNA A2059T mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
167436,,1835179,CHEMBL908708,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81F mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167437,,1835189,CHEMBL908709,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81Y and ParC D83Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167438,,1835199,CHEMBL908127,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 24 with GyrA S81Y, GyrB P413S and ParC S79F mutation after 10 antibiotic-free subcultures by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167439,,1835209,CHEMBL908128,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 2527 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167440,,1835219,CHEMBL908129,"Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 37 with GyrA S81Y, GyrB E474K and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167441,,1835402,CHEMBL919475,Antimicrobial activity against Burkholderia pseudomallei KHW,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167442,,1835407,CHEMBL919476,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 1000 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
167443,,1835412,CHEMBL919477,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 500 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
167444,,1835417,CHEMBL919478,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 250 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
167445,,1835422,CHEMBL919479,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 125 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
167446,,1835427,CHEMBL919480,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 62.5 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167447,,1835432,CHEMBL918917,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 31.3 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167448,,1835437,CHEMBL918918,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 15.6 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167449,,1835442,CHEMBL918919,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 7.8 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167450,,1835447,CHEMBL918920,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 3.9 uM prochlorperazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167451,,1835452,CHEMBL918921,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 1000 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
167452,,1835457,CHEMBL918922,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 500 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
167453,,1835462,CHEMBL918923,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 250 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167454,,1835467,CHEMBL918924,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 125 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167455,,1835472,CHEMBL918925,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 62.5 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167456,,1835477,CHEMBL918926,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 31.3 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167457,,1835482,CHEMBL918927,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 15.6 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167458,,1835487,CHEMBL918928,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 7.8 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167459,,1835492,CHEMBL918929,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 3.9 uM promazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167460,,1835497,CHEMBL918930,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 1000 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
167461,,1835502,CHEMBL918931,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 500 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
167462,,1835507,CHEMBL918932,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 250 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167463,,1835512,CHEMBL918933,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 125 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167464,,1835517,CHEMBL918934,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 62.5 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167465,,1835522,CHEMBL918935,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 31.3 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167466,,1835527,CHEMBL917956,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 15.6 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167467,,1835532,CHEMBL918938,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 7.8 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167468,,1835537,CHEMBL918939,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 3.9 uM omeprazole,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167469,,1835542,CHEMBL918946,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 1000 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
167470,,1835547,CHEMBL920351,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 500 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,8.0
167471,,1835552,CHEMBL920352,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 250 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
167472,,1835557,CHEMBL920353,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 125 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
167473,,1835562,CHEMBL920354,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 62.5 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167474,,1835567,CHEMBL920355,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 31.3 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167475,,1835572,CHEMBL920356,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 15.6 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167476,,1835577,CHEMBL920357,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 7.8 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167477,,1835582,CHEMBL920358,Antimicrobial activity against Burkholderia pseudomallei KHW in presence of 3.9 uM chlorpromazine,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142214,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,32.0
167478,,1836542,CHEMBL908125,Cytotoxicity against primary human osteoblasts at 400 ug/ml assessed as LDH release after 24 hrs,A,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,625762,=,1,0,=,Activity,%,40.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,40.0
167479,,1836544,CHEMBL909764,Cytotoxicity against primary human osteoblasts at 200 ug/ml assessed as LDH release after 24 hrs,A,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,625762,=,1,0,=,Activity,%,40.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,40.0
167480,,1836922,CHEMBL856456,Antibacterial activity against Streptococcus pneumoniae 1077 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167481,,1836928,CHEMBL856458,Antibacterial activity against Streptococcus pneumoniae 3243 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167482,,1836933,CHEMBL856462,Antibacterial activity against Streptococcus pneumoniae 2527 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625872,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167483,,1848548,CHEMBL919152,Antimicrobial activity against Streptococcus pneumoniae BSF-11524 isolate with erm(B) and L4 mutation,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167484,,1848555,CHEMBL919153,Antimicrobial activity against Streptococcus pneumoniae PC13 transformants,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167485,,1848562,CHEMBL919154,Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with erm(B) mutation,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167486,,1848569,CHEMBL919155,Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with L4 mutation,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167487,,1848576,CHEMBL919156,Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with L4 69GTG71 to TPS mutation,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167488,,1848583,CHEMBL919157,Antimicrobial activity against Streptococcus pneumoniae R6 transformants,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167489,,1848590,CHEMBL919158,Antimicrobial activity against Streptococcus pneumoniae R6 with L4 mutation,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167490,,1848597,CHEMBL919159,Antimicrobial activity against Streptococcus pneumoniae R6 with L4 69GTG71 to TPS mutation,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632125,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167491,,1848682,CHEMBL920582,Reduction of TNFalpha mRNA level in cystic fibrosis 16HBE14o-AS3 cells at 8 ug after 24 hrs relative to control,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,25.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,25.0
167492,,1848683,CHEMBL920583,Reduction of TNFalpha mRNA level in cystic fibrosis 2CFSMEo cells at 8 ug after 24 hrs relative to control,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,30.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,30.0
167493,,1848685,CHEMBL920585,Reduction of TNFalpha protein level in cystic fibrosis 16HBE14oAS3 cells at 8 ug after 24 hrs by ELISA relative to control,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,50.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,50.0
167494,,1848686,CHEMBL920586,Reduction of TNFalpha protein level in cystic fibrosis 2CFSMEo cells at 8 ug after 24 hrs by ELISA relative to control,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,40.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,40.0
167495,,1848688,CHEMBL920588,Reduction of NF-kappaB binding to DNA in cystic fibrosis 16HBE14o-AS3 cells at 8 ug after 24 hrs,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,45.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,45.0
167496,,1848689,CHEMBL920589,Reduction of NF-kappaB binding to DNA in cystic fibrosis 2CFSMEo cells at 8 ug after 24 hrs,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,45.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,45.0
167497,,1848691,CHEMBL920591,Reduction of Sp1 binding to DNA in cystic fibrosis 16HBE14o-AS3 cells at 8 ug after 24 hrs,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,64.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,64.0
167498,,1848692,CHEMBL920592,Reduction of Sp1 binding to DNA in cystic fibrosis 2CFSMEo cells at 8 ug after 24 hrs,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,=,1,0,=,Activity,%,65.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,65.0
167499,,1848693,CHEMBL920593,Cell viability of IB3-1 cells at 8 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,>,1,0,>,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167500,,1848695,CHEMBL920595,Cell viability of 16HBE14o-AS3 cells at 8 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,>,1,0,>,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167501,,1848696,CHEMBL920596,Cell viability of 16HBE14o-S1 cells at 8 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,>,1,0,>,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167502,,1848697,CHEMBL920597,Cell viability of 2CFSMEo cells at 8 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,>,1,0,>,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167503,,1848698,CHEMBL920598,Cell viability of IB3-1 cells at 16 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,<,1,0,<,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167504,,1848700,CHEMBL920600,Cell viability of 16HBE14o-AS3 cells at 16 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,<,1,0,<,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167505,,1848701,CHEMBL920601,Cell viability of 16HBE14o-S1 cells at 16 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,<,1,0,<,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167506,,1848702,CHEMBL920602,Cell viability of 2CFSMEo cells at 16 ug/ml after 24 hrs by trypan blue exclusion test,F,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1142091,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,632153,<,1,0,<,Activity,%,95.0,CHEMBL612546,,Molecular identity unknown,,,Activity,%,UO_0000187,95.0
167507,,1867980,CHEMBL918875,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
167508,,1867981,CHEMBL918875,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
167509,,1867990,CHEMBL919814,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
167510,,1867991,CHEMBL919814,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
167511,,1868000,CHEMBL919815,Antibacterial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,4.0
167512,,1868001,CHEMBL919815,Antibacterial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
167513,,1868012,CHEMBL919816,Antibacterial activity against Streptococcus viridans after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,ug ml-1,UO_0000274,1.0
167514,,1868013,CHEMBL919816,Antibacterial activity against Streptococcus viridans after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,ug ml-1,UO_0000274,4.0
167515,,1868134,CHEMBL919269,Antibacterial activity against Enterococcus faecalis,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,4.0
167516,,1868135,CHEMBL919269,Antibacterial activity against Enterococcus faecalis,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
167517,,1868147,CHEMBL919270,Antibacterial activity against Enterococcus faecium,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,16.0
167518,,1868148,CHEMBL919270,Antibacterial activity against Enterococcus faecium,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
167519,,1868155,CHEMBL919271,Antibacterial activity against Streptococcus pyogenes,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.12
167520,,1868156,CHEMBL919271,Antibacterial activity against Streptococcus pyogenes,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,8.0
167521,,1868163,CHEMBL919272,Antibacterial activity against Legionella pneumophila after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC,ug ml-1,UO_0000274,0.12
167522,,1868220,CHEMBL919273,Antibacterial activity against Mycoplasma pneumoniae after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.004
167523,,1868236,CHEMBL919274,Antibacterial activity against Haemophilus influenzae after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.5
167524,,1868237,CHEMBL919274,Antibacterial activity against Haemophilus influenzae after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,2.0
167525,,1868244,CHEMBL919809,Antibacterial activity against Moraxella catarrhalis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.015
167526,,1868245,CHEMBL919809,Antibacterial activity against Moraxella catarrhalis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.03
167527,,1868252,CHEMBL919806,Antibacterial activity against Neisseria gonorrhoeae after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC50,ug ml-1,UO_0000274,0.06
167528,,1868253,CHEMBL919806,Antibacterial activity against Neisseria gonorrhoeae after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC90,ug ml-1,UO_0000274,0.12
167529,,1868260,CHEMBL919275,Antibacterial activity against Neisseria meningitidis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.5
167530,,1868261,CHEMBL919275,Antibacterial activity against Neisseria meningitidis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634850,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,1.0
167531,,2123346,CHEMBL937078,Antimicrobial activity against macrolide-susceptible Mycobacterium avium by radiometric broth nanodilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143832,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703062,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC50,ug ml-1,UO_0000274,16.0
167532,,2123347,CHEMBL937078,Antimicrobial activity against macrolide-susceptible Mycobacterium avium by radiometric broth nanodilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143832,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703062,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC90,ug ml-1,UO_0000274,16.0
167533,,2123349,CHEMBL937079,Antimicrobial activity against macrolide-resistant Mycobacterium avium radiometric broth nanodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143832,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703062,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,512.0
167534,,2125046,CHEMBL952997,Antimicrobial activity against Streptococcus pneumoniae NMU112,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145502,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,705511,>=,1,1,>=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167535,,2125048,CHEMBL952999,Antimicrobial activity against Streptococcus pneumoniae NMU605,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145502,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,705511,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
167536,Active,2125059,CHEMBL953000,Reduction of pneumolysin production in Streptococcus pneumoniae NMU112 lysates at 5 ug/mL after 12 hrs by Western blot relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145502,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,705511,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167537,Active,2125063,CHEMBL953002,Inhibition of pneumococcal surface protein A production in Streptococcus pneumoniae NMU112 lysates at 5 ug/mL after 12 hrs by Western blot relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145502,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,705511,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167538,Active,2125087,CHEMBL936760,Antimicrobial activity against Streptococcus pneumoniae NMU112 infected in po dosed CBA/J mouse assessed as delaying in development of bacteremia relative to roxithromycin,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1145502,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,705511,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167539,,2126150,CHEMBL952138,In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,10.13,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,10134.3
167540,,2126158,CHEMBL951331,In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,1.623,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,1623.3
167541,,2126166,CHEMBL951332,In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs by SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,15.28,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,15277.0
167542,,2126174,CHEMBL951333,In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,2.734,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,2733.6
167543,,2126182,CHEMBL951334,In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,10.07,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,10073.4
167544,,2126190,CHEMBL951335,In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,1.848,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,1847.9
167545,,2126198,CHEMBL951336,In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,14.36,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,14364.7
167546,,2126206,CHEMBL951337,In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,4.489,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,4488.8
167547,,2126214,CHEMBL951338,Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,3.747,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,3746.8
167548,,2126222,CHEMBL951339,Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143813,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,701962,=,1,1,=,IC50,ug.mL-1,5.5,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng/ml,UO_0000274,5500.4
167549,,2127576,CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703545,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,0.5
167550,,2127577,CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703545,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,1.0
167551,,2127588,CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703545,=,1,1,=,MIC90,ug.mL-1,0.75,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.75
167552,,2127589,CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703545,=,1,1,=,MIC50,ug.mL-1,0.19,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.19
167553,,2197762,CHEMBL1008257,Antimalarial activity after 48 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,3464.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,3464.0
167554,,2197763,CHEMBL1008256,Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,103.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,103.4
167555,,2197764,CHEMBL1008255,Antimalarial activity after 48 hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,15742.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,15742.0
167556,,2197765,CHEMBL1008259,Antimalarial activity after 96hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,228.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,228.1
167557,,2197766,CHEMBL1008258,Antimalarial activity after 48 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,22585.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,22585.0
167558,,2197767,CHEMBL1008260,Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,43.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,43.3
167559,,2197786,CHEMBL1008254,Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 C1 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,95.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,95.7
167560,,2197787,CHEMBL1008261,Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 T76K1 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,121.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,121.8
167561,,2197788,CHEMBL1008253,Antimalarial activity after 96 hrs against Plasmodium falciparum 7G8 C1 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,141.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,141.8
167562,,2197789,CHEMBL1008262,Antimalarial activity after 96 hrs against Plasmodium falciparum 7G8 T76K1 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,114.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,114.8
167563,,2197790,CHEMBL995278,Antimalarial activity after 96hrs against Plasmodium falciparum GCO3 C2 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,48.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,48.0
167564,,2197791,CHEMBL995279,Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 C4 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,66.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,66.7
167565,,2197792,CHEMBL995280,Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 C6 mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,76.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,76.7
167566,,2197793,CHEMBL995281,Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 SDD mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,63.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,63.3
167567,,2197794,CHEMBL995282,Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 SND mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,47.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,47.8
167568,,2197795,CHEMBL995283,Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 CDY mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,70.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,70.2
167569,,2197796,CHEMBL995284,Antimalarial activity after 96 hrs against Plasmodium falciparum 3BA6 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,180.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,180.3
167570,,2197797,CHEMBL995285,Antimalarial activity against Plasmodium falciparum 3BA6 SDD with CRT and MDR1 mutation after 96 hrs in [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,154.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,154.7
167571,,2197798,CHEMBL995286,Antimalarial activity after 96 hrs against Plasmodium falciparum 3BA6 SND mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,157.9,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,157.9
167572,,2197799,CHEMBL995287,Antimalarial activity after 96 hrs against Plasmodium falciparum 3BA6 CDY mutant CRT/MDR1 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,194.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,194.2
167573,,2197800,CHEMBL995288,Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,1938.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,1938.7
167574,,2197801,CHEMBL995289,Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156420,J Biol Chem,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,764893,=,1,1,=,IC50,nM,3971.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,3971.7
167575,,2304417,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783682,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
167576,,2304423,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783682,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
167577,,2304429,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783682,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,64.0
167578,,2304435,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783682,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167579,,2304441,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783682,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,64.0
167580,,2304447,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783682,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,64.0
167581,,2415249,CHEMBL956076,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153924,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780395,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167582,,2415266,CHEMBL956077,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing erm gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153924,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780395,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167583,,2415283,CHEMBL956078,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing mef gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153924,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780395,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167584,,2415300,CHEMBL956079,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing erm and mef genes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153924,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780395,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167585,,2420375,CHEMBL964217,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate assessed as reduction of viable count in exponential phase at 256 ug/mL after 8 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,99.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,99.0
167586,,2420376,CHEMBL964216,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate assessed as reduction of viable count in exponential phase at 64 ug/mL after 8 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,87.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,87.0
167587,,2420377,CHEMBL964215,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate assessed as reduction of viable count in stationary phase at 16 ug/mL after 8 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,99.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,99.0
167588,,2420378,CHEMBL964213,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate assessed as reduction of viable count in stationary phase at 2 ug/mL after 8 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,88.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,88.0
167589,,2420379,CHEMBL964214,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate after overnight incubation by E-test,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782798,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
167590,Dose-dependent effect,2420380,CHEMBL964218,Inhibition of quorum sensing in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as suppression of GFP expression after 14 hrs by molecular technology,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167591,Non-toxic,2420381,CHEMBL964219,Toxicity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as growth rate at 2 to 12 ug/mL after 14 hrs by molecular technology relative to control,A,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167592,,2420382,CHEMBL953614,Inhibition of quorum sensing-regulated elastase production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 2 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,77.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,77.0
167593,,2420383,CHEMBL953615,Inhibition of quorum sensing-regulated elastase production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 4 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,45.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,45.0
167594,,2420384,CHEMBL953616,Inhibition of quorum sensing-regulated elastase production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 8 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,51.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,51.0
167595,,2420385,CHEMBL953617,Inhibition of quorum sensing-regulated chitinase production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 2 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,66.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,66.0
167596,,2421383,CHEMBL953618,Inhibition of quorum sensing-regulated chitinase production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 4 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,15.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,15.0
167597,,2421384,CHEMBL953619,Inhibition of quorum sensing-regulated chitinase production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 8 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,10.0
167598,,2421385,CHEMBL953620,Inhibition of quorum sensing-regulated pyocyanin production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 2 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,43.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,43.0
167599,,2421386,CHEMBL953621,Inhibition of quorum sensing-regulated pyocyanin production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 4 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,32.0
167600,,2421387,CHEMBL964236,Inhibition of quorum sensing-regulated pyocyanin production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 8 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,16.0
167601,,2421388,CHEMBL964237,Inhibition of quorum sensing-regulated alginate production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 2 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,63.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,63.0
167602,,2421389,CHEMBL964988,Inhibition of quorum sensing-regulated alginate production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 4 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,56.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,56.0
167603,,2421390,CHEMBL964989,Inhibition of quorum sensing-regulated alginate production in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene assessed as enzyme activity per cell at 8 ug/mL after 24 hrs relative to control,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,1,=,Inhibition,%,52.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,52.0
167604,,2421391,CHEMBL964990,Inhibition of alginate synthesis in Pseudomonas aeruginosa NH57388A mucoid isolate supernatant assessed as uronic acid concentration in inside of dialysis bag after equilibrium dialysis at 12 ug/mL after 24 hrs by carbazole-borate assay,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782798,=,1,0,=,Activity,ug ml-1,316.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,ug ml-1,UO_0000274,316.0
167605,,2421392,CHEMBL964991,Inhibition of alginate synthesis in Pseudomonas aeruginosa NH57388A mucoid isolate supernatant assessed as uronic acid concentration in outside of dialysis bag after equilibrium dialysis at 12 ug/mL after 24 hrs by carbazole-borate assay,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782798,=,1,0,=,Activity,ug ml-1,143.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,ug ml-1,UO_0000274,143.0
167606,,2421393,CHEMBL964992,Inhibition of alginate synthesis in Pseudomonas aeruginosa NH57388A mucoid isolate supernatant assessed as uronic acid fraction out of the dialysis bag of total amount of uronic acids after equilibrium dialysis at 12 ug/mL after 24 hrs by carbazole-borate assay,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,31.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,31.2
167607,,2421394,CHEMBL964993,Inhibition of alginate synthesis in Pseudomonas aeruginosa NH57388A mucoid isolate supernatant assessed as uronic acid concentration in dialysis bag before exhaustive dialysis at 12 ug/mL after 24 hrs by carbazole-borate assay,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782798,=,1,0,=,Activity,ug ml-1,316.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,ug ml-1,UO_0000274,316.0
167608,,2421395,CHEMBL964994,Inhibition of alginate synthesis in Pseudomonas aeruginosa NH57388A mucoid isolate supernatant assessed as uronic acid concentration in dialysis bag after exhaustive dialysis at 12 ug/mL after 24 hrs by carbazole-borate assay,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782798,=,1,0,=,Activity,ug ml-1,103.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,ug ml-1,UO_0000274,103.0
167609,,2421396,CHEMBL964995,Inhibition of alginate synthesis in Pseudomonas aeruginosa NH57388A mucoid isolate supernatant assessed as uronic acid fraction out of the dialysis bag of total amount of uronic acids after exhaustive dialysis at 12 ug/mL after 24 hrs by carbazole-borate assay,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,67.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,67.4
167610,,2421397,CHEMBL964996,Increase in sensitivity of hydrogen peroxide to Pseudomonas aeruginosa NH57388A mucoid isolate expressing quorum sensing lasI assessed as increase in zone of inhibition at 12 ug/mL after 48 hrs relative to untreated bacterial control,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,31.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,31.0
167611,,2421398,CHEMBL964997,Increase in sensitivity of hydrogen peroxide to quorum sensing lasI-deficient isogenic Pseudomonas aeruginosa NH57388A mucoid isolate mutant assessed as increase in zone of inhibition at 12 ug/mL after 48 hrs relative to untreated bacterial control,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,43.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,43.0
167612,,2421399,CHEMBL964999,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate expressing quorum sensing lasI assessed as reduction of viable count at 12 ug/mL in absence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'6/ml,31.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'6/ml,,31.0
167613,,2421400,CHEMBL965000,Antimicrobial activity against quorum sensing lasI-deficient isogenic Pseudomonas aeruginosa NH57388D mucoid isolate assessed as reduction of viable count at 12 ug/mL in absence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'6/ml,55.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'6/ml,,55.0
167614,,2421401,CHEMBL965001,Antimicrobial activity against Pseudomonas aeruginosa NH57388C nonmucoid isolate expressing quorum sensing lasI assessed as reduction of viable count at 12 ug/mL in absence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'5/ml,110.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'5/ml,,110.0
167615,,2421402,CHEMBL965002,Antimicrobial activity against quorum sensing lasI-deficient isogenic Pseudomonas aeruginosa NH57388E nonmucoid isolate assessed as reduction of viable count at 12 ug/mL in absence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'7/ml,3.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'7/ml,,3.8
167616,,2421403,CHEMBL965003,Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate expressing quorum sensing lasI assessed as reduction of viable count at 12 ug/mL in presence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'2/ml,2.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'2/ml,,2.5
167617,,2421404,CHEMBL964998,Antimicrobial activity against quorum sensing lasI-deficient isogenic Pseudomonas aeruginosa NH57388D mucoid isolate assessed as reduction of viable count at 12 ug/mL in presence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'5/ml,8.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'5/ml,,8.6
167618,,2421405,CHEMBL965004,Antimicrobial activity against Pseudomonas aeruginosa NH57388C nonmucoid isolate expressing quorum sensing lasI assessed as reduction of viable count at 12 ug/mL in presence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,ml,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,ml,UO_0000098,0.0
167619,,2421406,CHEMBL965005,Antimicrobial activity against quorum sensing lasI-deficient isogenic nonmucoid Pseudomonas aeruginosa NH57388E mutant assessed as reduction of viable count at 12 ug/mL in presence of 2.5% human normal serum,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,10'3/ml,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,10'3/ml,,2.0
167620,Active,2421407,CHEMBL965007,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse lungs assessed as reduction in GFP signal at 250 mg/kg, iv administered 24 hrs after infection measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167621,,2421408,CHEMBL954448,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse assessed as mortality at 500 mg/kg, po administered 24 hrs postinfection daily once for 5 days measured after 7 days postinfection",F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,24.0
167622,,2421409,CHEMBL954449,"Antimicrobial activity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse lungs assessed as median bacterial density per lung at 500 mg/kg, po administered 24 hrs after infection daily once for 5 days measured after 7 days postinfection",F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,=,1,0,=,CFU,,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,CFU,,,50.0
167623,,2421410,CHEMBL954450,"Antimicrobial activity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse lungs assessed as median alginate content in lungs at 500 mg/kg, po administered 24 hrs after infection daily once for 5 days measured after 7 days postinfection",F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782798,=,1,0,=,Activity,ug ml-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,ug ml-1,UO_0000274,10.0
167624,,2421411,CHEMBL954451,"Antimicrobial activity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse assessed as frequency of lung abscesses at 500 mg/kg, po administered 24 hrs after infection daily once for 5 days measured after 7 days postinfection",F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,782798,=,1,0,=,Activity,%,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,32.0
167625,Active,2421412,CHEMBL954452,"Antimicrobial activity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse lung assessed as debris-like granular material surrounding polymorphonuclear leukocytes at 500 mg/kg, po administered 24 hrs after infection daily once for 5 days measured after 7 days postinfection by histopathology",F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167626,Active,2421413,CHEMBL954453,"Antimicrobial activity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse lung assessed as fibrous spongy-like material surrounding polymorphonuclear leukocytes at 500 mg/kg, po administered 24 hrs after infection daily once for 5 days measured after 7 days postinfection by histopathology",F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167627,Active,2421414,CHEMBL954454,"Antimicrobial activity in Pseudomonas aeruginosa NH57388A mucoid isolate harboring GFP-fused avian sarcoma virus lasB gene infected in ftr-tml-Unc-TgN(FABPCFTR) cystic fibrosis mouse lung assessed as scattered residues of alginate without bacteria at 500 mg/kg, po administered 24 hrs after infection daily once for 5 days measured after 7 days postinfection by histopathology",F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153831,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,782798,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167628,,2495052,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779485,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,4.0
167629,,2495053,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779485,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
167630,,2495057,CHEMBL1028013,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,779485,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
167631,,2495077,CHEMBL1028014,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779485,>=,1,0,>=,Activity,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,2.0
167632,,2495087,CHEMBL1028015,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779485,<=,1,0,<=,Activity,ug ml-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,0.5
167633,,2495098,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779485,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167634,,2539195,CHEMBL976589,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1158114,J Nat Prod,2006.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,713187,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167635,,2539203,CHEMBL976590,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1158114,J Nat Prod,2006.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,713187,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
167636,,2539211,CHEMBL976591,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1158114,J Nat Prod,2006.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,713187,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167637,,2539219,CHEMBL976592,Antibacterial activity against Haemophilus influenzae ATCC 49247,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1158114,J Nat Prod,2006.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,713187,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,8.0
167638,,2628546,CHEMBL945686,Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,792058,=,1,1,=,IC50,nM,8670.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,8.67
167639,,2628552,CHEMBL945687,Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,792058,=,1,1,=,IC50,nM,52.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,0.0527
167640,,2628558,CHEMBL945688,Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,792058,=,1,1,=,IC50,nM,1460.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,1.46
167641,,2628564,CHEMBL945689,Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,792058,=,1,1,=,IC50,nM,31.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,0.031
167642,Not Active,2628586,CHEMBL948846,Antimalarial activity as arrested schizont maturation in chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 48 hrs at 100 nM dosed 96 hrs post infection,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,792058,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
167643,,2628590,CHEMBL948872,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96 hrs at 100 nM dosed 0-12 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,91.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,91.0
167644,,2628591,CHEMBL949899,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 0-24 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,61.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,61.0
167645,,2628592,CHEMBL949900,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 0-36 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,30.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,30.0
167646,,2628593,CHEMBL949901,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96 hrs at 100 nM dosed 0-48 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,17.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,17.0
167647,,2628594,CHEMBL949902,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 12-24 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,59.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,59.0
167648,,2628595,CHEMBL949903,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes assessed after 96hrs at 100 nM dosed 12-36 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,28.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,28.0
167649,,2628596,CHEMBL952715,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 12-48 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,18.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,18.0
167650,,2628597,CHEMBL952716,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 24-36 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,79.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,79.0
167651,,2628598,CHEMBL952717,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 24-48 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,68.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,68.0
167652,,2628599,CHEMBL952718,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 100 nM dosed 36-48 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,113.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,113.0
167653,Active,2628640,CHEMBL948850,Antimalarial activity as segregation of apicoplast in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 schizont infected human erythrocytes at 100 nM dosed 96 hrs post infection,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,792058,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
167654,Active,2628641,CHEMBL948851,Antimalarial activity as segregation of apicoplast in chloroquine-sensitive Plasmodium falciparum 3D7 progeny infected human erythrocytes at 100 nM dosed 96 hrs post infection,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,792058,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
167655,,2628648,CHEMBL948853,Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,105.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,105.0
167656,,2628652,CHEMBL948852,Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,792058,=,1,0,=,Activity,%,83.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,83.4
167657,,2628696,CHEMBL956218,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791979,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,2.0
167658,,2628697,CHEMBL956219,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791979,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,2.0
167659,,2628698,CHEMBL956220,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791979,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,2.0
167660,,2628720,CHEMBL956218,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791979,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,4.0
167661,,2628721,CHEMBL956219,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791979,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,4.0
167662,,2628722,CHEMBL956220,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791979,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,4.0
167663,,2628741,CHEMBL957019,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene assessed as susceptibility rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,791979,=,1,0,=,Activity,%,98.8,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,98.8
167664,,2628742,CHEMBL958670,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene assessed as susceptibility rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,791979,=,1,0,=,Activity,%,95.9,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,95.9
167665,,2628743,CHEMBL959506,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene assessed as susceptibility rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,791979,=,1,0,=,Activity,%,97.3,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,97.3
167666,,2628762,CHEMBL959510,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene assessed as resistance rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,791979,=,1,0,=,Activity,%,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,1.2
167667,,2628763,CHEMBL959511,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene assessed as resistance rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,791979,=,1,0,=,Activity,%,4.1,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,4.1
167668,,2628764,CHEMBL959512,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene assessed as resistance rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,791979,=,1,0,=,Activity,%,2.7,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,2.7
167669,,2659501,CHEMBL1036287,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 20 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167670,,2659526,CHEMBL1051483,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167671,,2659527,CHEMBL1051473,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167672,,2659528,CHEMBL1051468,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167673,,2659529,CHEMBL1051460,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167674,,2659530,CHEMBL1062983,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167675,,2659531,CHEMBL1023504,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167676,,2659532,CHEMBL1023494,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167677,,2659533,CHEMBL1023488,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167678,,2659534,CHEMBL1036288,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167679,,2659535,CHEMBL1036283,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.008
167680,,2659536,CHEMBL1052242,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167681,,2659537,CHEMBL1052246,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167682,,2659680,CHEMBL1051478,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 25 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167683,,2659681,CHEMBL1051477,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 21 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167684,,2659682,CHEMBL1051476,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 18 passages with levofloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167685,,2659683,CHEMBL1051475,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 19 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167686,,2659684,CHEMBL1051470,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167687,,2659685,CHEMBL1051469,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 35 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167688,,2659686,CHEMBL1051464,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 15 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167689,,2659687,CHEMBL1051462,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 29 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167690,,2659688,CHEMBL1051461,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 49 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167691,,2659689,CHEMBL1062986,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167692,,2659690,CHEMBL1062985,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 26 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167693,,2659691,CHEMBL1062984,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 38 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167694,,2659692,CHEMBL1062979,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167695,,2659693,CHEMBL1062978,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 44 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
167696,,2659694,CHEMBL1023505,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167697,,2659695,CHEMBL1023498,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 29 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167698,,2659696,CHEMBL1023497,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 33 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
167699,,2659697,CHEMBL1023496,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 41 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
167700,,2659698,CHEMBL1023495,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 20 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167701,,2659699,CHEMBL1023490,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167702,,2659700,CHEMBL1052241,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167703,,2659701,CHEMBL1023489,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 49 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167704,,2659702,CHEMBL1023485,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167705,,2659703,CHEMBL1023484,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167706,,2659704,CHEMBL1036285,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 20 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167707,,2659705,CHEMBL1036284,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 14 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167708,,2659706,CHEMBL1036280,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 48 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
167709,,2659707,CHEMBL1052245,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167710,,2659708,CHEMBL1052249,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 30 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167711,,2660238,CHEMBL1051465,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 29 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167712,,2660249,CHEMBL1051459,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
167713,,2660257,CHEMBL1062982,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167714,,2660265,CHEMBL1023501,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 33 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167715,,2660273,CHEMBL1023492,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167716,,2660297,CHEMBL1036282,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818242,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.008
167717,,2660378,CHEMBL1063872,Antimicrobial activity against Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolated from diabetic patient with calcaneal osteomyelitis by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151430,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818527,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC,ug ml-1,UO_0000274,8.0
167718,Not Active,2660379,CHEMBL1063873,Antimicrobial activity against 8 ug/ml colistin-subcultured Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolated from diabetic patient with calcaneal osteomyelitis and bacteremia by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151430,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,818527,,1,0,,MIC,,,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC,,,
167719,,2660549,CHEMBL1028720,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,65.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,65.5
167720,,2660550,CHEMBL1028721,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,87.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,87.9
167721,,2660551,CHEMBL1028722,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,35.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,35.5
167722,,2660552,CHEMBL1028723,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,19.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,19.4
167723,,2660553,CHEMBL1031224,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,34.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,34.0
167724,,2660554,CHEMBL1031225,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,11.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,11.3
167725,,2660555,CHEMBL1031226,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,64.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,64.5
167726,,2660556,CHEMBL1032050,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,80.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,80.6
167727,,2660940,CHEMBL1028716,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
167728,,2660941,CHEMBL1028717,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
167729,,2660942,CHEMBL1028718,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,4.0
167730,,2660943,CHEMBL1028719,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,32.0
167731,,2660968,CHEMBL1028716,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167732,,2660969,CHEMBL1028717,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
167733,,2660970,CHEMBL1028718,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167734,,2660971,CHEMBL1028719,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167735,,2660989,CHEMBL1032051,Antibacterial activity against Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,1.0
167736,,2660990,CHEMBL1032052,Antibacterial activity against beta lactamase-positive Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,1.0
167737,,2660991,CHEMBL1032053,Antibacterial activity against beta lactamase-negative Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,1.0
167738,,2661007,CHEMBL1032051,Antibacterial activity against Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,2.0
167739,,2661008,CHEMBL1032052,Antibacterial activity against beta lactamase-positive Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,2.0
167740,,2661009,CHEMBL1032053,Antibacterial activity against beta lactamase-negative Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,2.0
167741,,2661025,CHEMBL1032054,Antibacterial activity against Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,98.7,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,98.7
167742,,2661026,CHEMBL1032055,Antibacterial activity against beta lactamase-positive Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,98.1,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,98.1
167743,,2661027,CHEMBL1032056,Antibacterial activity against beta lactamase-negative Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,98.9,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,98.9
167744,,2661039,CHEMBL1032060,Antibacterial activity against Moraxella catarrhalis isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.12
167745,,2661046,CHEMBL1032060,Antibacterial activity against Moraxella catarrhalis isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.12
167746,,2661079,CHEMBL1032061,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients within 2 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167747,,2661080,CHEMBL1032062,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 3 to 5 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167748,,2661081,CHEMBL1032063,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 6 to 14 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167749,,2661082,CHEMBL1032064,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 15 to 64 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167750,,2661083,CHEMBL1032065,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients more than 65 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167751,,2661084,CHEMBL1032066,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients within 2 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,50.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,50.5
167752,,2661085,CHEMBL1032067,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 3 to 5 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,42.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,42.4
167753,,2661086,CHEMBL1032068,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 6 to 14 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,36.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,36.0
167754,,2661087,CHEMBL1032069,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 15 to 64 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,27.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,27.6
167755,,2661088,CHEMBL1032070,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients more than 65 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,33.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,33.8
167756,,2661089,CHEMBL1032071,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected male patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167757,,2661090,CHEMBL1032072,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected male patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,36.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,36.0
167758,,2661091,CHEMBL1032073,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected female patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167759,,2661092,CHEMBL1032074,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected female patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,31.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,31.2
167760,,2661093,CHEMBL1032075,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected inpatients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167761,,2661094,CHEMBL1032076,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected inpatients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,33.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,33.0
167762,,2661095,CHEMBL1032077,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected outpatients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817490,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
167763,,2661096,CHEMBL1032078,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected outpatients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,817490,=,1,0,=,Activity,%,34.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,34.8
167764,,2661127,CHEMBL1032866,Antibacterial activity against azithromycin-tolerant 0.01 MOI Chlamydia trachomatis L2AZM#31 harboring mutation in bacterial ribosomal protein L4 infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.8
167765,,2661128,CHEMBL1032865,Antibacterial activity against azithromycin-tolerant 0.01 MOI Chlamydia trachomatis L2AZM#23 harboring mutation in bacterial ribosomal protein L4 infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.8
167766,,2661129,CHEMBL1032864,Antibacterial activity against 0.01 MOI wild type Chlamydia trachomatis L2/LGV/434/Bu infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.1
167767,,2661130,CHEMBL1032080,Antibacterial activity against 0.01 MOI wild type Chlamydia psittaci 6BC BCRB infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,MIC,ug ml-1,UO_0000274,0.1
167768,,2661131,CHEMBL1032079,Biodistribution in healthy human epithelial lining fluid assessed as drug accumulation at 500 mg,A,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,=,1,0,=,Drug uptake,ug ml-1,2.0,CHEMBL612558,,ADMET,,,Drug uptake,ug ml-1,UO_0000274,2.0
167769,,2661132,CHEMBL1032081,Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ2 harboring A2058C mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,>,1,1,>,MIC,ug.mL-1,20.0,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,MIC,ug ml-1,UO_0000274,20.0
167770,,2661133,CHEMBL1032859,Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ5 harboring A2059C mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,>,1,1,>,MIC,ug.mL-1,20.0,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,MIC,ug ml-1,UO_0000274,20.0
167771,,2661134,CHEMBL1032860,Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ1 harboring A2059G mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817553,>,1,1,>,MIC,ug.mL-1,20.0,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,MIC,ug ml-1,UO_0000274,20.0
167772,Not Active,2661158,CHEMBL1032861,Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ2 harboring A2058C mutation in bacterial 23S rRNA gene infected in mouse L2 cells assessed as growth of infectious particles at 200 ng/ml treated 2 hrs after infection measured after 14 days by plaque assay relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,817553,,1,0,,Activity,,,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,Activity,,,
167773,Not Active,2661159,CHEMBL1032862,Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ5 harboring A2059C mutation in bacterial 23S rRNA gene infected in mouse L2 cells assessed as growth of infectious particles at 200 ng/ml treated 2 hrs after infection measured after 14 days by plaque assay relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,817553,,1,0,,Activity,,,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,Activity,,,
167774,Not Active,2661160,CHEMBL1032863,Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ1 harboring A2059G mutation in bacterial 23S rRNA gene infected in mouse L2 cells assessed as growth of infectious particles at 200 ng/ml treated 2 hrs after infection measured after 14 days by plaque assay relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151434,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,817553,,1,0,,Activity,,,CHEMBL614758,Chlamydia psittaci 6BC,Chlamydia psittaci 6BC,331636.0,,Activity,,,
167775,,2667052,CHEMBL1029498,Antibacterial activity against Escherichia coli isolates isolated from patients with Crohn's disease at 15 ug/disk by susceptibility testing disk method,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,820032,=,1,0,=,Activity,%,78.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,78.0
167776,,2667055,CHEMBL1032013,Antibacterial activity Escherichia coli isolate HM413 isolated from ileo-colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167777,,2667056,CHEMBL1029500,Antibacterial activity against Escherichia coli isolate HM154 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167778,,2667066,CHEMBL1029501,Antibacterial activity against Escherichia coli isolate HM580 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167779,,2667067,CHEMBL1032012,Antibacterial activity against Escherichia coli isolate HM615 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167780,,2667068,CHEMBL1032014,Antibacterial activity Escherichia coli isolate HM419 isolated from ileo-colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167781,,2667069,CHEMBL1032015,Antibacterial activity against Escherichia coli isolate HM95 isolated from ileal mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167782,,2667070,CHEMBL1032016,Antibacterial activity against mucosa-associated Escherichia coli isolate HM428 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167783,,2667071,CHEMBL1032017,Antibacterial activity against mucosa-associated Escherichia coli isolate HM454 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167784,,2667072,CHEMBL1032018,Antibacterial activity against mucosa-associated Escherichia coli isolate HM456 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,<=,1,1,<=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167785,Active,2667125,CHEMBL1029518,Antibacterial activity against extracellular Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease at 0.01 to 10 ug/ml after 3 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820032,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
167786,,2667156,CHEMBL1029507,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease in mouse J774A1 cells assessed as intracellular killing of bacteria at 0.4 ug/ml after 3 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,820032,=,1,0,=,Activity,%,41.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,41.0
167787,,2667510,CHEMBL1029502,Antibacterial activity against Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.0
167788,,2667511,CHEMBL1029505,Antibacterial activity against Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820032,=,1,0,=,MBC,ug ml-1,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,5.0
167789,,2667548,CHEMBL1032844,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,4.0
167790,,2667556,CHEMBL1032845,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by agar counting method,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,4.0
167791,,2667564,CHEMBL1032846,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as minimum drug level resulting in no detectable growth at 10'6 CFU of inoculum after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,16.0
167792,Not Evaluated,2667572,CHEMBL1032842,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at >10'2 CFU of inoculum by MGIT 960 susceptibility test,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820035,,1,0,,Activity,,,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,,,
167793,Not Evaluated,2667580,CHEMBL1032843,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at 10'5 CFU of inoculum by MGIT 960 susceptibility test,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820035,,1,0,,Activity,,,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,,,
167794,,2667588,CHEMBL1033614,Antituberculosis activity against Mycobacterium paratuberculosis JTC303 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,1.0
167795,,2667592,CHEMBL1033615,Antituberculosis activity against Mycobacterium paratuberculosis JTC303 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,4.0
167796,,2667596,CHEMBL1033616,Antituberculosis activity against Mycobacterium paratuberculosis UCF-4 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,1.0
167797,,2667600,CHEMBL1033617,Antituberculosis activity against Mycobacterium paratuberculosis UCF-4 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,2.0
167798,,2667604,CHEMBL1033618,Antituberculosis activity against Mycobacterium paratuberculosis UCF-5 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,0.5,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,0.5
167799,,2667608,CHEMBL1033619,Antituberculosis activity against Mycobacterium paratuberculosis UCF-5 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,2.0
167800,,2667612,CHEMBL1033620,Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,0.5,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,0.5
167801,,2667616,CHEMBL1033621,Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,1.0
167802,,2667620,CHEMBL1033622,Antituberculosis activity against Mycobacterium paratuberculosis B213 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,1.0
167803,,2667624,CHEMBL1033623,Antituberculosis activity against Mycobacterium paratuberculosis B213 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,2.0
167804,,2667628,CHEMBL1033624,Antituberculosis activity against Mycobacterium paratuberculosis B236 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,0.5,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,0.5
167805,,2667632,CHEMBL1033625,Antituberculosis activity against Mycobacterium paratuberculosis B236 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,4.0
167806,,2667636,CHEMBL1033626,Antituberculosis activity against Mycobacterium paratuberculosis B238 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,>,1,0,>,Activity,ug ml-1,0.5,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,0.5
167807,,2667640,CHEMBL1033627,Antituberculosis activity against Mycobacterium paratuberculosis B238 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,Activity,ug ml-1,UO_0000274,1.0
167808,,2667644,CHEMBL1033628,Antituberculosis activity against Mycobacterium avium ATCC 35712 isolated from chicken assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,Activity,ug ml-1,UO_0000274,1.0
167809,,2667648,CHEMBL1033629,Antituberculosis activity against Mycobacterium avium ATCC 35712 isolated from chicken assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820035,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,Activity,ug ml-1,UO_0000274,16.0
167810,,2674025,CHEMBL1026150,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167811,,2674028,CHEMBL1026149,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
167812,,2674033,CHEMBL1026148,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167813,,2674039,CHEMBL1026147,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
167814,,2674044,CHEMBL1026146,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167815,,2674050,CHEMBL1026145,"Antibacterial activity against penicillin-, quinolone-resistant Streptococcus pneumoniae HMC 1541 harboring mutation in L4 protein by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167816,,2674056,CHEMBL1026144,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167817,,2674062,CHEMBL1026143,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167818,,2674068,CHEMBL1026142,"Antibacterial activity against penicillin-, quinolone-resistant and macrolide-susceptible Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
167819,,2674074,CHEMBL1031971,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167820,,2674080,CHEMBL1031970,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 441 expressing ermB by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167821,,2674086,CHEMBL1031969,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167822,,2674092,CHEMBL1031968,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167823,,2674098,CHEMBL1031967,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167824,,2674104,CHEMBL1031966,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167825,,2674110,CHEMBL1031965,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167826,,2674116,CHEMBL1031964,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167827,,2674943,CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
167828,,2674952,CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.06
167829,,2674961,CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
167830,,2674970,CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
167831,,2674979,CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
167832,,2674988,CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,64.0
167833,,2674997,CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.12
167834,,2675006,CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
167835,,2675015,CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
167836,,2675024,CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
167837,,2675033,CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
167838,,2675042,CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
167839,,2675051,CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
167840,,2675061,CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
167841,Not Determined,2675070,CHEMBL1026151,Antibacterial activity against Streptococcus pneumoniae HMC 3041 after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,819270,,1,0,,MIC,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,,,
167842,Not Determined,2675074,CHEMBL1026152,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,819270,,1,0,,MIC,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,,,
167843,,2675077,CHEMBL1026153,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167844,Not Determined,2675083,CHEMBL1026154,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae HMC 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,819270,,1,0,,MIC,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,,,
167845,,2675088,CHEMBL1026155,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167846,,2675094,CHEMBL1026156,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167847,,2675100,CHEMBL1026974,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 41 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167848,,2675106,CHEMBL1026975,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 42 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167849,,2675112,CHEMBL1026976,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene after 22 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167850,,2675118,CHEMBL1026977,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S79Y mutation in quinolone-resistant determining regions of ParC gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
167851,,2675124,CHEMBL1026978,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 28 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167852,,2675130,CHEMBL1026979,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 36 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167853,,2675136,CHEMBL1026980,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 49 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167854,,2675142,CHEMBL1026981,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and I460V, D435N mutation in QRDR of ParE gene after 46 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167855,,2675148,CHEMBL1029503,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring I460V mutation in QRDR of ParE gene after 41 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
167856,,2675154,CHEMBL1031996,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F, E85K mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 27 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.016
167857,,2675162,CHEMBL1031999,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 38 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167858,,2675168,CHEMBL1032774,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 44 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819270,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
167859,,2676174,CHEMBL1052991,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as maximal doubling time at 0.125 ug/mL using flow cell culture after 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#MinuteTime,820116,=,1,0,=,Activity,min,44.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,min,UO_0000031,44.0
167860,Not Active,2676176,CHEMBL1052993,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as growth inhibition at 0.125 ug/mL using static culture after 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167861,,2676178,CHEMBL1052995,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820116,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
167862,Active,2676180,CHEMBL1052997,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease biofilm formation at 0.125 ug/mL after 2 days using flow cell culture relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167863,Active,2676181,CHEMBL1052998,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease biomass of biofilm at 0.125 ug/mL after 2 days using flow cell culture relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167864,Active,2676182,CHEMBL1052999,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease maximal thickness of biofilm at 0.125 ug/mL after 2 days using flow cell culture relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167865,Active,2676183,CHEMBL1053000,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biomass of biofilm in 2 days established biofilm at 0.125 ug/mL after 4 days using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167866,Active,2676184,CHEMBL1053001,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in maximum thickness of biofilm in 2 days established biofilm at 0.125 ug/mL after 4 days using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167867,Not Active,2676185,CHEMBL1053002,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biomass of biofilm at 0.125 ug/mL incubated for 2 days measured after day 4 using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167868,Not Active,2676186,CHEMBL1053003,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in maximal thickness of biofilm at 0.125 ug/mL incubated for 2 days measured after days 4 using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167869,Active,2676187,CHEMBL1053004,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biofilm formation at 0.125 ug/mL treated for 4 days measured on day 2 to 4 using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167870,Active,2676188,CHEMBL1053005,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in established biofilm formation at 0.125 ug/mL treated for 4 days measured on day 2 to 4 using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167871,Active,2676199,CHEMBL1055362,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S34 assessed as inhibition of biofilm formation at >64 ug/mL,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167872,Active,2676200,CHEMBL1055363,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S43 assessed as inhibition of biofilm formation at >64 ug/mL,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167873,Active,2676201,CHEMBL1055364,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S44 assessed as inhibition of biofilm formation at >64 ug/mL,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167874,Active,2676202,CHEMBL1055365,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S61 assessed as inhibition of biofilm formation at >64 ug/mL,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167875,Active,2676203,CHEMBL1055366,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as inhibition of biofilm formation at 0.25 ug/ml after 7 hrs using crystal violet,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167876,Active,2676204,CHEMBL1055367,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S52 assessed as inhibition of biofilm formation at 8 ug/mL after 7 hrs using crystal violet,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167877,Active,2676205,CHEMBL1055368,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S53 assessed as inhibition of biofilm formation at 16 ug/mL after 7 hrs using crystal violet,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167878,Active,2676206,CHEMBL1055369,Antimicrobial activity against azithromycin-resistant nontypeable Haemophilus influenzae isolate S57 assessed as inhibition of biofilm formation at 64 ug/mL after 7 hrs using crystal violet,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167879,Not Active,2676207,CHEMBL1055370,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as viability at 0.125 ug/mL after 2 days using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167880,Not Active,2676208,CHEMBL1055371,Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as viability at 0.125 ug/mL incubated for 2 days measured on day 4 using flow cell culture,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151453,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,820116,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
167881,,2676288,CHEMBL1054590,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC50,ug.mL-1,0.00049,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.00049
167882,,2676289,CHEMBL1054591,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,32.0
167883,,2676290,CHEMBL1054592,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,32.0
167884,,2676312,CHEMBL1054590,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC90,ug.mL-1,0.00098,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,0.00098
167885,,2676313,CHEMBL1054591,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,64.0
167886,,2676314,CHEMBL1054592,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,64.0
167887,,2677044,CHEMBL1054590,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC,ug.mL-1,0.00024,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.00024
167888,,2677045,CHEMBL1054591,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,>=,1,1,>=,MIC,ug.mL-1,16.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,16.0
167889,,2677046,CHEMBL1054592,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818614,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,16.0
167890,Active,2680691,CHEMBL1057982,Inhibition of rhamnolipid production in Pseudomonas aeruginosa PT1300 harboring vector pEX1.8 up to 50 ug/ml incubated for 24 hrs at 37 degC further 24 hrs at 25 degC,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167891,Not Active,2680692,CHEMBL1057983,Inhibition of rhamnolipid production in Pseudomonas aeruginosa PT1308 expressing Clostridium perfringens 23S rRNA methylase ErmBP at 50 ug/ml incubated for 24 hrs at 37 degC further 24 hrs at 25 degC,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167892,Active,2680693,CHEMBL1057984,Inhibition of rhamnolipid production in azithromycin-hypersusceptible Pseudomonas aeruginosa 11B harboring mexX deletion mutant incubated for 24 hrs at 37 degC further 24 hrs at 25 degC,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167893,Not Active,2680694,CHEMBL1057985,Inhibition of rhamnolipid production in Pseudomonas aeruginosa 12B overexpressing mexXY incubated for 24 hrs at 37 degC further 24 hrs at 25 degC,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167894,Dose-dependent effect,2680695,CHEMBL1057986,Inhibition of elastase production in Pseudomonas aeruginosa PT1300 harboring vector pEX1.8 after 18 hrs by elastin Congo red assay,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167895,Not Active,2680696,CHEMBL1057987,Inhibition of elastase production in Pseudomonas aeruginosa PT1308 expressing Clostridium perfringens 23S rRNA methylase ErmBP at 2 to 4 ug/ml after 18 hrs by elastin Congo red assay,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167896,Active,2680697,CHEMBL1057988,Inhibition of swarming motility of Pseudomonas aeruginosa PT1300 harboring vector pEX1.8 at 2 ug/ml after 18 hrs,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167897,Not Active,2680698,CHEMBL1057989,Inhibition of swarming motility of Pseudomonas aeruginosa PT1308 expressing Clostridium perfringens 23S rRNA methylase ErmBP at 2 ug/ml after 18 hrs,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167898,Dose-dependent effect,2680699,CHEMBL1057990,Bactericidal activity against stationary-phase Pseudomonas aeruginosa PT1300 culture harboring vector pEX1.8 after 20 to 22 hrs by plating serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167899,Not Active,2680700,CHEMBL1057991,Bactericidal activity against stationary-phase Pseudomonas aeruginosa PT1308 culture expressing Clostridium perfringens 23S rRNA methylase ErmBP assessed as effect on cell viability at 1 to 16 ug/ml after 22 hrs by plating serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167900,Not Active,2680701,CHEMBL1057992,Bactericidal activity against stationary-phase Pseudomonas aeruginosa PT1300 culture harboring vector pEX1.8 at 1 to 16 ug/ml after 22 hrs by plating serial dilution method in presence of 1 mM Mg2+,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167901,Not Active,2680702,CHEMBL1057993,Bactericidal activity against stationary-phase Pseudomonas aeruginosa PT1308 culture expressing Clostridium perfringens 23S rRNA methylase ErmBP at 1 to 16 ug/ml after 22 hrs by plating serial dilution method in presence of 1 mM Mg2+,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167902,,2680703,CHEMBL1057994,Bactericidal activity against Pseudomonas aeruginosa PT1323 harboring rhlAB-encoding pAKRHL at 2 to 18 ug/ml after 22 hrs by plating serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,=,1,0,=,Activity,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,4.0
167903,,2680704,CHEMBL1057995,Bactericidal activity against Pseudomonas aeruginosa PT1332 rhlA mutant harboring vector pAK1900 at 2 to 18 ug/ml after 22 hrs by plating serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,=,1,0,=,Activity,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,1.0
167904,Not Active,2680705,CHEMBL1057997,Antimicrobial activity against exponential-phase Pseudomonas aeruginosa PT1323 cultures harboring mutation in bacterial rhlA protein and expressing rhamnosyltransferase rhlAB gene at 1 mg/ml after 18 hrs by susceptibility assay,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
167905,,2680706,CHEMBL1058784,Ratio of bactericidal activity against Pseudomonas aeruginosa PT712 harboring mutation in bacterial rhlA protein to bactericidal activity against wild type Pseudomonas aeruginosa PAO1 PT5,F,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,823507,=,1,0,=,Ratio,,1000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Ratio,,,1000.0
167906,Not Active,2680707,CHEMBL1057996,Inhibition of rhamnolipid production in Pseudomonas aeruginosa PT1323 harboring pAKRHL expressing rhlAB gene up to 50 ug/ml incubated for 24 hrs at 37 deg C further 24 hrs at 25 deg C,F,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152455,Antimicrob Agents Chemother,2007.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://qudt.org/vocab/unit#Percent,823507,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
167907,,2684952,CHEMBL1056341,Antimicrobial activity against Acinetobacter baumannii BM4454 isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824437,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,96.0
167908,,2684964,CHEMBL1056342,Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeABC adeIJK double mutant isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824437,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.5
167909,,2684976,CHEMBL1056343,Antimicrobial activity against Acinetobacter baumannii BM4579 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824437,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,96.0
167910,,2684988,CHEMBL1056344,Antimicrobial activity against Acinetobacter baumannii BM4651 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824437,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.5
167911,,2685000,CHEMBL1063234,Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824437,=,1,1,=,MIC,ug.mL-1,24.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,24.0
167912,,2685012,CHEMBL1063235,Antimicrobial activity against Acinetobacter baumannii BM4579 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824437,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,96.0
167913,Not Active,2695244,CHEMBL1063987,Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes 07Z016 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
167914,Not Active,2695245,CHEMBL1063986,Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes 07Z014 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
167915,Not Active,2695246,CHEMBL1063985,Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes 07Z011 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
167916,Active,2695247,CHEMBL1063984,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes 07U086 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
167917,Active,2695248,CHEMBL1063983,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes 07U084 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
167918,Not Active,2695249,CHEMBL1063982,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae 05Z006 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167919,Not Active,2695250,CHEMBL1063981,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae 07Z001 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167920,Active,2695251,CHEMBL1063980,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae 07H252 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167921,Active,2695252,CHEMBL1063979,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152401,Bioorg Med Chem Lett,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,822350,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
167922,,2702686,CHEMBL1061685,Inhibition of Escherichia coli ribosome,B,BAO_0000190,BAO_0000220,subcellular format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153505,Bioorg Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,828588,=,1,1,=,IC50,nM,300.0,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,IC50,uM,UO_0000065,0.3
167923,,2711829,CHEMBL1051721,Antiplasmodial activity after 48 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,827181,=,1,1,=,IC50,nM,9040.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,9.04
167924,,2711830,CHEMBL1051722,Antiplasmodial activity after 72 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,827181,=,1,1,=,IC50,nM,4570.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,4.57
167925,,2711831,CHEMBL1051723,Antiplasmodial activity after 96 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,827181,=,1,1,=,IC50,nM,940.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,0.94
167926,,2711832,CHEMBL1051724,Antiplasmodial activity after 120 hrs against Plasmodium falciparum 3D7 as Malstat LDH activity,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/Nanomolar,827181,=,1,1,=,IC50,nM,410.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,0.41
167927,Active,2711843,CHEMBL1051726,Antiplasmodial activity against Plasmodium falciparum 3D7 as early schizont maturation arrest at IC50 after 48-120 hrs by giemsa stain,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,827181,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
167928,Active,2711846,CHEMBL1051730,Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as multiple-nuclei schizont arrest at IC50 after 96 hrs by transmission electron microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,827181,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
167929,,2711854,CHEMBL1051727,Relative activity against Plasmodium falciparum 3D7 as IC50 ratio after 48 and 96 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1152993,Antimicrob Agents Chemother,2008.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,827181,=,1,0,=,Ratio IC50,,10.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Ratio IC50,,,10.0
167930,,2718334,CHEMBL1056744,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167931,,2718335,CHEMBL1056745,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae after 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
167932,,2718336,CHEMBL1056746,Antibacterial activity against efflux-mediated macrolide-resistant Streptococcus pneumoniae after 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167933,,2718337,CHEMBL1056747,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin-resistant Streptococcus pneumoniae after 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167934,,2718338,CHEMBL1056748,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes after 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.125
167935,,2718339,CHEMBL1056749,Antibacterial activity against inducible macrolide-lincosamide-streptogramin-resistant Streptococcus pyogenes 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
167936,,2718340,CHEMBL1056750,Antibacterial activity against efflux-mediated macrolide-resistance Streptococcus pyogenes after 16 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,4.0
167937,,2718341,CHEMBL1056751,Antibacterial activity against Moraxella catarrhalis ATCC 23246 after 16 to 22 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.125
167938,,2718342,CHEMBL1056752,Antibacterial activity against Haemophilus influenzae ATCC 49247 after 16 to 22 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
167939,,2718343,CHEMBL1056753,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16 to 22 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
167940,,2718344,CHEMBL1059207,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 22 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1153576,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830255,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
167941,,2910787,CHEMBL1040384,Antibacterial activity against erythromycin-resistant Staphylococcus pneumoniae A22072 encoded by mef gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154057,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,4.0
167942,,2910826,CHEMBL1040383,Antibacterial activity against erythromycin-resistant Staphylococcus pneumoniae B1 encoded by erm gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154057,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847704,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,128.0
167943,,2910865,CHEMBL1040382,Antibacterial activity against erythromycin-susceptible Staphylococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154057,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847704,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.03
167944,,2910926,CHEMBL1040385,Antibacterial activity against erythromycin-resistant Staphylococcus pneumoniae AB11 encoded by erm and mef gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154057,Eur J Med Chem,2009.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847704,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,256.0
167945,,2994791,CHEMBL1043580,Fraction unbound in human plasma,A,BAO_0000179,BAO_0000366,cell-free format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1156824,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,,861647,=,1,1,=,Fu,,0.88,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,Fu,,,0.88
167946,,3195280,CHEMBL1110317,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by standard dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154807,Eur J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,893097,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
167947,,3195294,CHEMBL1110318,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by standard dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154807,Eur J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,893097,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
167948,,3195308,CHEMBL1110319,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by standard dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154807,Eur J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,893097,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167949,,3195322,CHEMBL1110320,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 by standard dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154807,Eur J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,893097,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167950,,3195336,CHEMBL1110321,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 by standard dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154807,Eur J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,893097,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167951,,3195350,CHEMBL1110322,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB11 by standard dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1154807,Eur J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,893097,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167952,,3274466,CHEMBL1111114,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1157905,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,912738,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.064
167953,,3274475,CHEMBL1111115,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae PU11 encoded by erm and mef gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1157905,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,912738,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167954,,3274484,CHEMBL1111116,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae PU13 encoded by erm and mef gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1157905,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,912738,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167955,,3274493,CHEMBL1112973,Antimicrobial activity against erythromycin-susceptible Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1157905,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,912738,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167956,,3274502,CHEMBL1109210,Antimicrobial activity against erythromycin-susceptible Staphylococcus aureus PU19 encoded by erm(A) gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1157905,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,912738,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
167957,,3274511,CHEMBL1109211,Antimicrobial activity against erythromycin-susceptible Staphylococcus aureus PU32 encoded by erm(A) gene,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1157905,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,912738,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167958,,3305811,CHEMBL1120597,Antimicrobial activity against macrolide-sensitive Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
167959,,3305812,CHEMBL1120598,Antimicrobial activity against macrolide-sensitive Streptococcus pneumoniae SPO 30,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,<,1,1,<,MIC,ug.mL-1,0.13,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.13
167960,,3305813,CHEMBL1120599,Antimicrobial activity against macrolide-sensitive Streptococcus pyogenes 3665,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,<,1,1,<,MIC,ug.mL-1,0.13,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.13
167961,,3305814,CHEMBL1120600,Antimicrobial activity against macrolide-resistant Streptococcus pneumoniae Ci137,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167962,,3305815,CHEMBL1120601,"Antimicrobial activity against inducible macrolide, lincosamide, streptogramin-resistant Streptococcus pyogenes Finland 11",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,16.0
167963,,3305816,CHEMBL1120602,"Antimicrobial activity against inducible macrolide and constitutive lincosamide, streptogramin-resistant Streptococcus pneumoniae 4636",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167964,,3305817,CHEMBL1120603,Antimicrobial activity against Haemophilus influenzae ATCC 49247,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
167965,,3305965,CHEMBL1120607,Antimicrobial activity against macrolide-sensitive Staphylococcus aureus PK1,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167966,,3305966,CHEMBL1117918,Antimicrobial activity against inducible macrolide-resistant Streptococcus pyogenes Finland 3,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
167967,,3305967,CHEMBL1120604,"Antimicrobial activity against inducible macrolide, lincosamide, streptogramin-resistant Streptococcus pneumoniae 134 GRM",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167968,,3305968,CHEMBL1120605,"Antimicrobial activity against inducible macrolide and constitutive lincosamide, streptogramin-resistant Streptococcus pneumoniae 58 Spain",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167969,,3305969,CHEMBL1120606,"Antimicrobial activity against inducible macrolide and constitutive lincosamide, streptogramin-resistant Streptococcus pyogenes 166 GR-micro",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155520,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915708,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167970,,3306099,CHEMBL1117919,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155521,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915751,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
167971,,3306100,CHEMBL1117920,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing erm gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155521,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915751,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
167972,,3306101,CHEMBL1117921,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing mef gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155521,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915751,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167973,,3306102,CHEMBL1117922,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB1-1 expressing erm and mef gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1155521,Bioorg Med Chem Lett,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915751,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
167974,,3385712,CHEMBL1221123,Antimicrobial activity against Neisseria meningitidis M7mtrE::Spc by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212761,Antimicrob Agents Chemother,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929378,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.125
167975,,3385714,CHEMBL1221121,Antimicrobial activity against Neisseria meningitidis M7 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212761,Antimicrob Agents Chemother,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929378,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,2.0
167976,,3385719,CHEMBL1221122,Antimicrobial activity against Neisseria meningitidis M7tolC::Kan by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212761,Antimicrob Agents Chemother,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929378,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,2.0
167977,,3385720,CHEMBL1221124,Antimicrobial activity against Neisseria meningitidis M7tolC::Kan mtr::Spc by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212761,Antimicrob Agents Chemother,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929378,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.125
167978,,3408233,CHEMBL1219287,Antibacterial activity against erythromycin A-resistant Staphylococcus aureus B0329 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
167979,,3408264,CHEMBL1219288,Antibacterial activity against inducible macrolide-lincosamide-streptogramin B-resistant Staphylococcus aureus B0538 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167980,,3409316,CHEMBL1219289,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B-resistant Staphylococcus aureus B0330 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167981,,3409347,CHEMBL1219290,Antibacterial activity against efflux-resistant Staphylococcus aureus B0331 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167982,,3409378,CHEMBL1219291,Antibacterial activity against erythromycin A-resistant Streptococcus pneumoniae B0541 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
167983,,3409409,CHEMBL1219292,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B-resistant Streptococcus pneumoniae B0627 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167984,,3409440,CHEMBL1219293,Antibacterial activity against efflux-resistant Streptococcus pneumoniae B0326 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
167985,,3409471,CHEMBL1219294,Antibacterial activity against erythromycin A-resistant Streptococcus pyogenes B0542 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.125
167986,,3409502,CHEMBL1219295,Antibacterial activity against inducible macrolide-lincosamide-streptogramin B-resistant Streptococcus pyogenes B0543 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
167987,,3409533,CHEMBL1219296,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B-resistant Streptococcus pyogenes B0544 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167988,,3409564,CHEMBL1219297,Antibacterial activity against efflux-resistant Streptococcus pyogenes B0545 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,1.0
167989,,3409595,CHEMBL1219298,Antibacterial activity against Moraxella catarrhalis B0324 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.25
167990,,3409626,CHEMBL1219299,Antibacterial activity against Haemophilus influenzae B0529 by agar microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1212927,J Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933641,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
167991,,3414781,CHEMBL1225484,"Antibacterial activity against inducible resistance to macrolide, licosamide, and streptogramin Staphylococcus aureus 90265/97 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167992,,3414782,CHEMBL1225483,Antibacterial activity against inducible resistance to macrolide and constitutive resistance to lincosamide Streptococcus pneumoniae 134 GR M by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167993,,3414783,CHEMBL1225482,"Antibacterial activity against inducible resistance to macrolide, licosamide and streptogramin Streptococcus pyogenes 11 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,16.0
167994,,3414784,CHEMBL1225481,Antibacterial activity against efflux-mediated macrolide-resistance Staphylococcus aureus PK1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
167995,,3414785,CHEMBL1225480,Antibacterial activity against efflux-mediated macrolide-resistance Streptococcus pneumoniae Ci137 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
167996,,3414786,CHEMBL1225479,Antibacterial activity against efflux-mediated macrolide-resistance Streptococcus pyogenes 2 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
167997,,3414787,CHEMBL1225478,Antibacterial activity against constitutive MLS resistance Streptococcus pneumoniae 58 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
167998,,3414788,CHEMBL1225477,Antibacterial activity against constitutive MLS resistance Streptococcus pyogenes 166 GR-Micro by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
167999,,3414789,CHEMBL1225476,Antibacterial activity against Haemophilus influenzae ATCC 49247 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,CHEMBL1221321,Bioorg Med Chem,2010.0,CHEMBL529,AZITHROMYCIN,CHEMBL529,0,http://www.openphacts.org/units/MicrogramPerMilliliter,937763,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
